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Abstract

Patient survival post liver transplant (LT) is important to both the patient and the center’s
accreditation, but over the years physicians have noticed that distant patients struggle with post
LT care. I hypothesized that patient’s distance from the transplant center had a detrimental effect
on post LT survival. I suspected Hepatitis C (HCV) and Hepatocellular Carcinoma (HCC) patients
would deteriorate due to their recurrent disease and there is a need for close monitoring post LT.
From the current literature it was not clear if patients’ distance from a transplant center affects
outcomes post LT. Firozvi et al. (Firozvi AA, 2008) reported no difference in outcomes of LT
recipients living 3 hours away or less. This study aimed to examine outcomes of LT recipients
based on distance from a transplant center. I hypothesized that the effect of distance from a LT
center was detrimental after adjusting for HCV and HCC status.

Methods:
This was a retrospective single center study of LT recipients transplanted between 1996 and
2012. 821 LT recipients were identified who qualified for inclusion in the study. Survival analysis
was performed using standard methods as well as a newly developed Monte Carlo (MC)
approach for change point detection. My new methodology, allowed for detection of both a
change point in distance and a time by maximizing the two parameter score function (M2p) over a
two dimensional grid of distance and time values. Extensive simulations using both standard
distributions and data resembling the LT data structure were used to prove the functionality of the
model.

vii

Results:
Five year survival was 0.736 with a standard error of 0.018. Using Cox PH it was demonstrated
that patients living beyond 180 miles had a hazard ratio (HR) of 2.68 (p-value<0.004) compared
to those within 180 miles from the transplant center. I was able to confirm these results using KM
and HCV/HCC adjusted AFT, while HCV and HCC adjusted LR confirmed the distance effect at
180 miles (p=0.0246), one year post LT. The new statistic that has been labeled M2p allows for
simultaneous dichotomization of distance in conjunction with the identification of a change point in
the hazard function. It performed much better than the previously available statistics in the
standard simulations. The best model for the data was found to be

; ,  



 exp 

    ! "  #$ % which dichotomizes the distance Z, replacing it by I(Z>c), and then

estimates the change point c and .
Conclusions:

Distance had a detrimental effect and this effect was observed at 180 miles from the transplant
center. Patients living beyond 180 miles from the transplant center had 2.68 times the death rate
compared to those living within the 180 mile radius. Recipients with HCV fared the worst with the
distance effect being more pronounced (HR of 3.72 vs. 2.68). Extensive simulations using
different parameter values in both standard simulations and simulations resembling LT data,
proved that these new approaches work for dichotomizing a continuous variable and finding a
point beyond which there is an incremental effect from this variable. The recovered values were
very close to the true values and p-values were small.

viii

Chapter One
Introduction

1.1 Distance Effect on Post-Transplant Survival
Patient survival post-transplant is important to both the patient and a transplant center’s
accreditation, especially given the scarcity of donor organs and the increasing demand for them.
Physicians and patients work closely to improve survival of transplant patients, so a thorough
understanding of factors affecting this is an important key to improving post-transplant survival.
Over the years, physicians had noticed that patients who travelled further to visit the transplant
center experienced more challenges with post-transplant care. Although there were a few papers
on this topic, most used a very short follow up period of one year during which surgical
complications come into play and had majority of the patients living closest to the LT center
(Firozvi et al., 2008, Axelrod et al., 2008, Kemmer et al., 2011, Zorzi et al., 2012). I decided to
revisit this topic with a larger number of patients in a retrospective study of all patients at Tampa
General Hospital. I hypothesized that further distance of the patient’s residence from the liver
transplant center leads to worse survival post LT. This study aimed to examine outcomes of liver
transplant recipients based on distance from a transplant center. I examined the distance effect
using cubic regression splines to detect nonlinearity, and with Akaike Information Criterion (AIC)
and a Monte Carlo (MC) approach used to determine a distance cutoff.

1.2 Literature Review on Outcomes
Since liver transplant was first performed by Dr. Starzl in 1963, it has become widely indicated for
patients with fatal acute and chronic end stage liver diseases (ESLD) (Starzl et al., 1982). Over
6000 LTs are performed each year in the U.S., with improved survival noted in the recent years
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(Alsina et al., 2009). A donor and recipient disparity in LT currently exists (Merion, 2009; Merion
et al., 2005). United Network for Organ Sharing (UNOS) was established in 1987 to ensure
equitable access to these organs (Tuttle, Curley, Roh, 1997). It is also important to identify
patients who can obtain most survival benefit (Merion et al., 2005). Thus, guidelines for liver
allocation have evolved over the years to achieve the best outcome for all patients in need of LT.

Since 2002, UNOS has incorporated the use of Model for End Stage Liver Disease (MELD) to
modify liver allocation (Freeman et al., 2002). MELD is a formula based on objective laboratory
values, with some exception points such as those given for hepatocellular carcinoma (HCC) to
determine patients’ risk of death and hence the need for LT. This is an excellent and successful
example of how statistical models can be translated into policy.

One of the goals of this dissertation is to investigate whether statistical models can also be used
to identify patients at higher risk of death after LT. Freeman et al. (2002) have recognized that
post-transplant risk models will be important as they add to the pre-transplant risk models such
that scarce organs will not only benefit patients with the highest risk of dying without LT, but also
achieve highest chance of survival with the LT.

I was interested in studying the distance effect on outcome after LT. However, most of the
geographical literature emphasized allocation disparities before LT. It has been shown that LT
candidates who live far from a LT center had less chance of receiving a LT (Tuttle et al., 1997).
Distant patients also had higher rate of death and dropout from the list due to worsening of their
medical conditions (Zorzi et al., 2012). They were less likely to be called in as a “backup” patient
and less likely to be admitted during times of emergency (Firozvi et al., 2008). Given access
disparities that arise from distance barriers pre-transplant, I hypothesized that the distance would
also affect post LT outcome.

2

There has been a dearth of literature evaluating the association between residential distance from
a LT center and post LT survival. Through literature review, I have identified only two studies
from the U.S., both of which yielded unexpected results. Firozvi et al. (2008) showed that patients
who lived more than 3 hours away had similar outcomes to those who lived closer for all of the
following: listing, transplantation, and 1 year survival after LT. Axelrod et al. (2008) examined the
distance effect on outcome via discussion of urban vs. rural settings. Nearly 14% of US
population does not live in major urban areas where LT centers are predominately located;
patients with long travel distance are those from rural and small town settings. Their study
showed that rural and small town residents had lower wait list registration rate and lower
transplant rate for liver, compared to urban residents. However, once a patient was wait listed,
the wait time among rural residents was not longer, and the post-LT survival was not different
(Axelrod et al., 2008).

Due to the donor and recipient disparity in LT that currently exists (Merion, 2009), it is important
to maximize the utility of transplantation, whether measured by post LT survival, rejection, access
to post-transplant care, quality of life, or other variables. UNOS plans to modify liver allocation in
order to make waiting time more uniform across the country for patients with similar disease
severity. However, these models do not specifically address post-transplant benefits (Freeman et
al., 2002; Washburn, 2008, 2012; Washburn, Pomfret, & Roberts, 2011). One aspect of LT that
had not been thoroughly studied was the impact of the patient’s distance (residence) from the
transplant center on post-transplant survival, although it is already known that distance was a
detriment to access and being listed for liver transplantation (Axelrod et al., 2008; Kemmer,
Alsina, & Neff, 2011; Park et al., 2012; Park et al., 2011).

Distance or geographical studies in liver transplantation are rare and tightly interwoven with
concepts of 1) allocation models, 2) large vs. small centers and their claims of superior ability to
care for patients at long distances vs. to serve their community, 3) post-transplant care, 4)
insurance carriers and centers of excellence, 5) and overall utility of transplants (Axelrod et al.,
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2008; Firozvi et al., 2008; Kemmer et al., 2011; Park et al., 2012; Park et al., 2011). This study
was conducted because it remained unclear to us if the patient’s distance from the transplant
center affected the outcome post liver transplantation.

Five years ago, a study published in Liver Transplantation, caught my attention. It concluded that
distance does not adversely affect outcomes (Firozvi et al., 2008). The conclusion of this study
and the editorial comment (Washburn, 2008) that it received were of much interest, which
prompted me to restudy this topic. In the Firozvi study, based on 66 transplant patients, a survival
analysis was conducted utilizing a small number of patients at long distances. Lack of statistical
power due to the small sample size may have explained the similar survival curves. The study
only focused on survival at one year post-transplant, a time period too short to evaluate the
multiple difficulties that the patients may encounter in their post-transplant course of care. These
include, but are not limited to, Hepatitis C (HCV) and Hepatocellular Carcinoma (HCC)
recurrence, compliance, and medical complications of transplantation. In addition, using one
specific cutoff point for distance that is predetermined ahead of time, excluded the possibility of
discovering a different and more appropriate cutoff that might have been further or closer to the
transplant center than what was initially suspected.

Axelrod et al. (2008) found that rural patients had worse survival, while Park et al. (2011) reported
that pediatric rural LT patients did not have worse survival. There are some who argued that rural
health care, in general, is of lower quality than that provided in urban settings because better
prepared or more competent health care providers would be attracted to urban centers where
there would be more opportunities and access to cultural and academic functions than can be
found in rural settings. Axelrod et al. (2008) looked at 174,630 patients who underwent heart,
liver or kidney transplantation with an accrual period of 5 years (1999-2004). Each of these
organs was different with respect to follow-up and expected outcomes. Because heart and
kidney transplant care can be different from LT care, it is impossible in this study to determine the
effect of distance on LT patients’ survival. For example, patients who received a kidney
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transplant were able to receive follow-up care from their local nephrologist, whereas patients who
received a liver transplant had to follow-up with the center that performed the transplant. This
made the issue of distance more important in LT recipients as opposed to those receiving a
kidney. Also this study examined rural vs. urban residence which was not necessarily the same
as the effect of driving distance from the transplant center.

The study by Park et al. (2011) found that rurality did not significantly affect health outcomes after
LT in 388 pediatric patients. The authors used urban influence (UI) codes published by the US
Department of Agriculture (USDA) to stratify patients as urban or rural depending on county of
residence. Again, rural vs. urban does not necessarily reflect distance from the transplant center.
This study also differed from mine in that their population consisted of pediatric LT patients. They
included patients with UNOS status 1 (fulminant hepatic failure) who received priority on the
waiting list because these patients only had hours to live without a transplant. Logistic regression
models were used in their papers that disregarded the length of survival. By contrast, I used, Cox
PH and AFT models that take into account the actual duration of survival. In addition, other
studies used a pre-specified mileage/driving time cutoff whereas my study allowed that cutoff to
be data driven. In a later study, Park et al. (2012) examined 3,307 pediatric LT patients and
found that rural location had a negative impact on patient health within the first 6 months of LT by
increasing the risk for allograft rejection, although patients in rural areas had lower rates of
developing post LT lymphoproliferative disorder.

Several studies addressed the effect of distance on pre-transplant survival and waiting time to LT.

Kemmer et al. (2011) examined the time between diagnosis and transplant. While distance did
not appear to affect access to transplant, it did not necessarily preclude a distance effect on
survival post-transplant. In this paper only 439 patients were studied and the median distance
was 36.8 miles with a range of 0.5 to 231 miles. The present study included a larger sample size
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of 821 patients living a median distance of 27.8 miles with a range of 0 to 548 miles from the
transplant center.

Zorzi et al. (2012) studied 5,673 candidates listed for liver transplant in UNOS Region 4 between
2004 and 2010. The authors established that there was a deterioration in survival on the waiting
list for patients living more than 30 miles from the transplant center in patients with Model for End
stage Liver Disease (MELD) score over 20 (p-value<0.0001). The 30 mile intervals were prespecified as 0-30, 30-60 and over 60 with the cutoffs not dictated by the data. Methodology
included Kaplan Meier and Cox PH, but survival post-transplant was not studied. It was also
specific to those with MELD scores over 20, whereas my study pertained to the entire LT
population.

Barritt et al. (2012) assessed the effect of distance on whether or not the patient received a LT.
The mean distance to the primary transplant center did not differ between those who were
transplanted and those who were not. Age, race, sex, distance to transplant centers, and rural vs.
urban residence did not influence the odds of receiving a liver transplant (Barritt, Telloni, Potter,
Gerber, & Hayashi, 2012).

It is important to note that distance from a transplant center can lead to selection bias in those
receiving a transplant. Liver failure patients living far from a liver transplant center had less
chance of receiving transplantation (Benach & Amable, 2004; McCormick et al, 2004). Distant
patients had difficulty navigating through the transplant process, even after referral. These
distant patients were also less likely to be called in as a “backup” patient (Washburn et al., 2011),
which reduced their chances of successful transplantation, therefore reducing survival. The
differential probability of transplantation by distance needs to be considered, because it can result
in those transplanted patients living at longer distances being in poorer health than those living
closer to the transplant center.
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My study was different from previous studies in the following ways: First, it utilized a larger
number of patients overall (821 vs. 66 in Firozvi et al.) with more at longer distances. Second, it
followed liver transplant recipients for up to 5 years post transplantation vs. one year in previous
studies (Firozvi et al., 2008). Third, it excluded patients who relocated temporarily to be closer to
the transplant center for purposes of receiving a transplant. Hence, this significant bias present in
other studies such as that by Firozvi et al., was eliminated. Fourth, adjustment was made for
important covariates, such as HCV and HCC which recurred affecting survival.

1.3 Literature Review of the Methods
The Kaplan-Meier (KM) estimator, the most widely used method for estimating survivor functions
in biomedicine, is also known as the product-limit estimator because the estimated survival
probabilities are computed using a product limit formula (Kleinbaum & Klein, 2012). Researchers
were using this method for many years prior to 1958 when Kaplan and Meier showed that it was a
nonparametric maximum likelihood estimator, therefore giving it a solid theoretical justification
(Allison, 2010). When there are no censored data the KM estimator &'  is just the sample

proportion of observations with event time greater than t. When censoring is present then for a
given time t all the event times that are less than or equal to t are taken and for each of those
event times, the probability of surviving to time

()* ,

given that one has survived to time

computed using the following formula:
&'   + ,1 -

where at each time
who die at time ( .

(

(: 2342

(

is

.(
0
/(

there are /( individuals at risk of death and .( is the number of individuals

The log-rank test compares two or more survival curves using a null hypothesis of a common
survival curve. It is based on the summed observed minus expected score for a given group and
its variance estimate with k-1 degrees of freedom where k is the number of groups (Kleinbaum &
Klein, 2012). The log-rank statistic can be written as

7

7

5 .*( - 6*( 
(8*

summing over all unique event times in every group. The expected number of events in group 1
at time j, 6*( 

9:3;3
93

. The Wilcoxon statistic is a weighted sum of the deviations of observed

number of deaths from the expected number of deaths given by
7

5 /( .*( - 6*( 
(8*

This test puts more weight on early times as compared to late times since /< always decreases;

therefore it is less sensitive than the log-rank test to differences between groups that occur at
later on in time.

The Cox PH model (Cox, 1972) can be written as
=>   



 exp? * @>*  A 

B @>B C

This equation illustrates that the hazard for an individual D at time t is the product of a linear

function of a set of k fixed covariates which is then exponentiated and the baseline hazard
function



. Partial likelihood enables estimation of the coefficients β of the proportional

hazards model without, having to specify the baseline hazard function, except for the restriction
that it must be positive. Assumptions include non-informative censoring and proportional
hazards, but the model can be generalized to allow for non-proportional hazards. In my study,
Breslow’s method was employed for handling ties (Breslow, 1974).

In contrast to the Cox PH, the Accelerated Failure Time (AFT) model, depicts a relationship

between the survivor functions of any two individuals. If &>   is the survivor function for individual
i, then for another individual j, the AFT model states that &>    &( E>(  for all t where E>( is a

constant that is specific to the pair (i, j) so what makes one individual different from another is the
rate at which they age. The model can be written as
Log Ti = β0 + β1xi1 + ………+βkxik +σεi

where F> denotes the event time for the i individual, @>* , … , @>B are the values of k covariates for
th
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that same individual, H> is a random disturbance term, and

, … ,

B and

I are parameters to be

estimated. AFT models have the advantage that they allow distributions of ε besides the normal
distribution but retain assumptions of constant mean and variance, and independence across
observations (James, 2005; Keiding, Andersen, & Klein, 1997).

Some typical distributions for the AFT model can be found below. Usually for parametric models,
the shape parameter p would be held fixed and λ re-parameterized in terms of predictor variables
and regression parameters. The AFT was used in the past for modeling kidney transplant data
(Lambert, Collett, Kimber, & Johnson, 2004) but not LT.

Table 1: Common AFT Distributions
Distribution
Exponential
Weibull
Log-Logistic

f(t)

J

exp- 

KL*

exp-

J
1 

KL*

K M

S(t)

K

h(t)

exp- 



exp1
1

K

K



J

KL*

J KL*
1 K

The logistic regression (LR) model is most appropriate when events can only occur at regular,
discrete points in time. With my data, it was used at 1 year post LT with 739 patients eligible for
inclusion. Eighty-two patients were excluded from this analysis because they did not have one
th

year’s worth of follow-up at the time this study ended (September 25 2012) although they were
alive. I felt it was a useful model for this data since ties arise from grouping continuous data into

intervals (Albert & Anderson, 1984; Hilbe, 2009). Allowing N>2 to be the conditional probability that
individual i has an event at time t, given that the individual has not already had an event, then the
logistic regression equation is
log R

N>2
S  T2 
1 - N>2

* @>2*

 A

B @>2B

The KM and Cox PH were the most frequently used in the literature due to the ease of
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interpretation. AFT models required more stringent assumptions about the distribution of the data
so they were not used as often. AFT had the advantage of a completely specified hazard and
survival function but required an assumption about the underlying distribution. The Cox PH
model does not rely on distributional assumptions and the baseline hazard is not necessary for
estimation of the hazard ratio. However the distribution of the survival time is unknown and it is
less consistent with the theoretical survival function as it is usually a step function. LR ignores
valuable information concerning the length of survival post-transplant and provides only a snap
shot at a particular point in time (1 year in this study).

Akaike’s Information Criterion (AIC) is a measure of the goodness of fit of an estimated statistical
model (Bozdogan, 1987). It is an operational way of trading off the complexity of an estimated
model against how well the model fits the data. I used this criterion to establish the best possible
cutoff point for distance in Cox PH models.

Boisson et al. (2008) studied the survival time as affected by the rate of degradation of quality of
life and extended the partial likelihood score statistic to apply to survival time. Goodman et al.
(2011) used data driven methods to estimate both the number of change points in the hazard
function and where those change points occurred. An alpha spending function was used where
T U V 

W

MXY:

for the overall significance level α to ensure strong evidence for choosing a more

complicated model. Nelder and Mead (1965) developed a Wald-type test statistic that uses the
Nelder-Mead Simplex optimization algorithm, which is robust but relatively slow. Specifically they
tested sequentially for the presence of an additional change point using Z : TBL* - TB  0 vs
Z* : TBL* - TB \ 0 where the test statistic was ] 

^ XY: LW
^ X _
W

^ XY: LW
^X
`a7 W

which was distributed as a b M

with one degree of freedom. Once a null hypothesis could not be rejected then one stops and
concludes that there were no more change points. A simulation study successfully demonstrated
the strength of this new method and found that power was most affected by sample size. Change
points were restricted to larger than the first non-censored survival time and smaller than the last
non-censored survival time.
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Liang et al (1990) introduced a variant of the Cox PH model and used age as the time variable
and  as the change point. However their method required the time invariant condition that

c  lim9fg h

i_ j

ik _

L*

0, , #, l

h

i_ j

ikim

0, , #, l was independent of . This time invariant

condition of c usually did not hold when there existed additional covariates X and their
coefficients n \ 0.

Matthews et al. (1982) presented a likelihood ratio test for detecting a single change point. They
used the following hazard function:
  o

*,
q *,

pr
!

Since standard asymptotic likelihood inference on the parameters

* , q,

and  was not possible,

they used maximum likelihood estimators and unconditional procedures. The log-likelihood test
statistic for the null hypothesis   0, is Δ  t '* , qu, ̂  - t ' , ' , 0, where ' was the maximum

likelihood estimator of the failure rate in a simple exponential model. Although it would have been
naïve to apply asymptotic likelihood ratio theory to conclude that 2Δ had a b M distribution with 2
M
degrees of freedom, the percentiles of the bM
distribution agreed quite well with the simulation

results.

Nguyen, Rogers, and Walker (1984) pointed out that the likelihood was unbounded under the

alternative hypothesis since a singularity appeared as q f ∞ and  was taken immediately before
the largest observation. Matthews et al. (1985) removed the singularity by considering the data
as discrete and reformulated the likelihood as a product of probabilities rather than densities.
They proposed tests based on maximal score statistics and derived the asymptotic significance

levels. Yao (1986) suggested constraining the estimate of  proposed previously by Matthews,

Farewell, and Pyke (1985) so it did not fall in the interval between the two largest observations.
Worsley (1988) found that the singularity could be removed if the largest observation was
artificially considered to be censored.
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Chang, Chen, and Hsiung (1994) proposed an estimator for the change-point ̂ that was easier to

implement and could be considered a nonparametric counterpart of the estimator resulting from
the score process proposed by Matthews et al (1985). Henderson (1990) suggested some
modified likelihood ratio tests with the most important modification involving a weighted and
standardized likelihood ratio value, which leads to a higher power and a smaller mean squared

error for . Loader (1991) derived large deviation approximations to the significance level of the
likelihood ratio test by a random change of time scale for the empirical process.

Akman and Raferty (1986) analyzed a change-point Poisson process and provided point and
interval estimates of the change-point. They investigated the small-sample performance of the
proposed procedures by means of a Monte-Carlo study. Raftery and Akman (1986) developed a
comparable Bayesian approach. A kernel method for the estimation of the change-point of the
most rapid change of a continuous hazard function was then proposed by Müller and Wang
(1990).

Kleinbaum (1996) found that the assumption of proportional hazards was not always relevant in
the whole range of the covariate and the covariate could be dichotomized to satisfy this
assumption. Kleinbaum’s procedure led to a two-phase Cox model with a change-point
according to a threshold that may be fixed or estimated from the data. Other authors considered
a non-regular Cox model involving a two-phase regression and time-dependent covariates, with a
change-point at an unknown time (Liang, Self, and Liu, 1990; Luo, 1996; Luo, Turnbull, and Clark,
1997).

Pons (2003) studied the asymptotic behavior of the maximum partial likelihood estimator of the
parameters in a non-regular Cox model with a change-point according to the unknown threshold
of a covariate. In their model, the hazard rate of a survival time F  had the form
k

|

  exp?yk  C with yk    T z *   
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z
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where   ,  z z ,   T z ,

z

, # z z ,

was an unknown baseline hazard function and  

*z , Mz ,  z was a vector of covariates.

Zucker and Lakatos (1990) presented two weighted log rank type statistics designed to have
good efficiency over a wide range of lags. One was a maximum efficiency robust statistic, while
the second was a simplified version of this statistic. Both of these were substantially more
efficient than the conventional log rank statistic. This was an attractive method because it
required no modeling assumptions. When there was a lag in the effect of a certain covariate, the
proportional hazards assumption was violated causing the log rank test to be inefficient and
therefore a weighted version was best. However, choosing weights is a non-trivial issue. Self et
al. (1988) suggested an approach for choosing weights when the lag function was equal to some
function. Another approach taken by the Physician’s Health Committee was to give positive
weight only to the portion of the trial during which one felt fairly certain that all or most of the full
treatment effect was present, but this approach had serious drawbacks as early adverse effects
could be overlooked (Physician's, 1983). Zucker and Lakatos’ (1990) approach included all
events so there was no risk of proving a treatment to be beneficial when there were early adverse
effects; however their approach down-weighed early events even though they did not completely
exclude them.

The goal of this study was to search for two types of change points in the hazard function: one

with respect to distance c and the other with respect to time . It was possible that the distance

effect was not present initially but became evident later on in the patient follow-up, after a time
point . In addition I suspected that the distance effect began after a point c, with a potentially

increasing effect beyond this point [max(z-c,0)]. Identifying change points in a hazard function
was of great importance in survival analysis and I was particularly interested in the Monte Carlo
approach used by Liu et al. (2008). It was computationally efficient, avoided technical
assumptions that would be difficult to verify, and gave a legitimate p-value for the test for the
existence of a change point at an unspecified location, which other methods failed to do.
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1.3.1 Background
The hazard function (Liu et al., 2008) could be specified with one change point as

 ; ,  

and for two change points as

 ; ,  





 exp?   p C  #$ 

exp ?  *  p *   M  p M C  #$ 

where λ t was an unspecified baseline hazard function,  > 0 was the change-point parameter,
θ was the magnitude of change after the change point, β was the throughout distance effect on

the hazard function, Z was distance from LT center which caused the non-constant hazard, η
were the coefficients and X(t) were other risk factors that I adjusted for (HCV and HCC). Using
this model I determined the presence of change points in the hazard as well as the magnitude of
change in distance effect before and after the change-point .

Let F>  minF> , >  and >  F> p >  where F> and > denote the failure time and censoring

th
th
time for the i subject. Define >    F> p , >  1 as the count of failures on the i subject at

time t, >    F>   the at-risk indicator, and   inf ? ; JyF !   0C the shortest time t such

that it is not possible for both survival time and censoring time to exceed it. For a trial with n

subjects, the partial likelihood for the unknown parameters (θ, β, n , τ) based on the observed
data is

9

 , , n,   + 
>8*





exp?   p C>  n  >  
.  
∑9(8* (   exp?   p C(  n  (   >

Complications arise with the Likelihood Ratio Test since the likelihood is not a smooth function of
the change-point  and under the null hypothesis of no change-point Z :   0, the parameter 
disappears from the likelihood (Liang et al. 1990; Matthews et al. 1985). Matthews et al. (1985)
proposed a maximal score statistic as an alternative, but the normalized score process indexed
by the change-point parameter must converge to an O-U process. An O-U process is a
stochastic/random process that is stationary, Gaussian and Markovian. It is a modification of
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random walk where the process drifts toward the mean. Since the technical assumptions for the
limiting O-U process were difficult to verify in semi-parametric models (Liang et al., 1990), there
was a need for improved methodology.
Liu et al (2008) let #   , n   and >U  > , > $ and defined the non-normalized score statistic as
&k #;  

 t. ; 
|
  k8,8

and the corresponding normalized score statistic as
k #;  

&kM #; 
 #; 

where # is the restricted maximum partial likelihood estimates under Z and #;  is the

variance estimator of &k #;  evaluated under the null hypothesis. If the change point is
suspected to lie in a region  then maximizing over this region gives

  sup  |&k #; | and  U  sup  k #; 

Liang et al. (1990) proposed something similar to M*, but they imposed a technical assumption

that B() was independent of , so when  was a fixed time interval then the normalized score

process converged to an O-U process, where
c  lim9fg h

i_ j

i k_

L*

0, , n, l

o

i_ j

ikim

0, , n,  (Liang et al., 1990)

This time-invariant condition of B() usually did not hold in the presence of additional covariates
when the coefficients were not zero (η≠0). As an alternative Liu et al. (2008) used an efficient
Monte Carlo method to evaluate the statistical significance for both M and M* which did not

require the technical assumption that B() was independent of  nor the special O-U process

covariance structure for the normalized score process. This approach numerically approximated
the joint distribution of {&k  #; ,   } and kept within process correlation intact.
1.3.2 Monte Carlo Method

Under Z :   0, .>    .>   - >   exp?# >U  C .Λ   is a martingale, where # is the true
value of # and Λ    ¢

2

 £.£ .

Let ¤, #;  be the negative second derivative matrix of the
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log partial likelihood at a supposed change-point time . By the law of large numbers

/L* ¤0, #;  converges to a matrix ∑ under Z :   0. Using a Taylor series expansion

&k #;  is asymptotically equivalent to ∑9>8* &¥k,> 0, # ;  which is a sum of n independent random

variables with mean zero where &¥k,> 0, # ;   &k,> 0, # ;  - ∑k ∑L*
  &,> 0, # ;  or as a
martingale integral

B
U
U
&¥k,> 0, # ;   ¢  p ?> - ¦̃  C - ∑k ∑L*
 ?>   - @¨  C.>  

- (*)

Here ∑kk , ∑ and ∑k are the components of ∑ according to the partition of  and #.
*©
M &k #
;

Under the null hypothesis /L

 converges to a zero-mean Gaussian process, the limiting

M
0, # ;  , and the covariance is
variance is    lim9fg /L* ∑9>8* &¥k>

 * , M   lim /
9fg

L*

9

5 &¥k> 0, # ; *  &¥k> 0, # ; M 
>8*

Replacing the unknown parameters in &¥k,> 0, # ;  with consistent estimators under the null (with

L*
0, #; ?>U   the exception of ) &'k,>   ¢  p ?> -   ; #C - ¤k 0, #;  ¤
B

ª>  
U  C.

«   and Λ
«    ∑9>8* ¢2
ª>    .>   - >   exp?#$>U C .Λ
where .
 ∑

;¬ ®
 ³3U ®C
3́µ: ¯3 ®°±² ?

.

M
Therefore at each time , /L*  #,   /L* ∑9>8* &'k,>
 is a consistent estimate for the asymptotic

variance of /L

*©
M &k #
;

 under the null hypothesis Z :   0.

In order to approximate the distribution of the test statistics proposed by Liu et al. (2008), they
define

&'k #;   ∑9>8* &'k,> ¶> where {¶> , ·  1, , … , /} are independent standard normal random

variables that act as disturbance factors in the sum and agree that the randomly perturbed variant
&'k #; , given the observed data, has the same limiting distribution as &k #;  (proof in (Lin,

'M
ªk #;   &k  #; ¸
Wei, & Ying, 1993)). Likewise k #;  can be approximated by 
 #, .

ªk #;  are used to
A large number of randomly disturbed score processes &'k #;  and 
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ª U  sup  
ª  sup  |&'k #; | and 
ªk #;  respectively, and the empirical
calculate 
ª and 
ª U.
quantiles of 

The Monte Carlo resampling procedure outlined above has several advantages:

1. The components to construct &'k,>  are only calculated once and reused to find the
variance  #, .

2. The score statistic process only jumps at the observed failure times so when searching

for a change point over the candidate region , test statistics are only calculated at the
observed death times.

In the event that distance was associated with L change points * ¹ A ¹ º with an effect on the

hazard function where L >1, then the hazard function is defined as
 ; ,  



º

 exp»  5 j 
j8*

 ¼j ½¾   n$ 

where ¼* ½  0, * , ¼M ½  * , M , … ¼ºL* ½  ºLM , ºL* , ¼º ½  º ,  are intervals

subdividing the study period K (which is 5 years in my case). The interval ºL* , º  is not needed
because the model is already saturated over 0,  without it.

Under multiple change points where ¿ and ½ were L x1 vectors, the partial likelihood function
becomes

9

 ¿, , #, ½  + 
>8*





exp?  ∑ºj8* j   ¼j ½C>  n  >  
.  
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The null hypothesis for multiple change points is Z# : *  A  º  0. Then the normalized
maximal score test statistic for testing Z# has the form  #  sup::,…Á Á k# #; * , . . º 

where ?* , … º C are the proposed regions in which the change points ?* , … , º C lie respectively.
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The method used to evaluate statistical significance used numerous randomly disturbed score
statistics that were generated over all the potential change points. Those were then used to
compute the 100(1-α) quantile of the Monte Carlo resampled maximal score statistics which was
used as the critical threshold. The proportion of simulation samples in which the null hypothesis
of no effect was rejected at the 0.05 level of significance when the null was false defined the
empirical power (Leffondré, Abrahamowicz, & Siemiatycki, 2003; Væth & Skovlund, 2004). Type
II error was computed as 1-power. The empirical type I error was the proportion of p-values less
than the nominal 0.05 significance level (under a true null) from testing the null hypothesis on
each simulated sample (Rempala & Looney, 2006). These values were computed and reported
for each of the 4 extensions described next in the methods.

1.4 Statement of the Problems/ Applications and Significance
The methods described above were not sufficient for detecting change points in the hazard while
simultaneously dichotomizing distance. This brought forth an opportunity for improvement in the
existing methodology of the Monte Carlo approach to change point detection which was first
proposed by Liu et al. (2008). This research required a more complicated null hypothesis which
simultaneously dichotomized distance at a point c and located the time τ such that the distance
effect was observed for times greater than τ. This required maximizing the partial likelihood over
a grid of distance and time values. My approach required substantial modifications of standard
methods in survival analysis and the use of very recently developed methods that were not yet in
common use and described only in journal articles (Liu et al., 2008). The goal was to best
establish the mileage point at which survival post-transplant declined and the time point posttransplant at which the hazard changed, while adjusting for the effects of multiple covariates
observed at the time of transplant.

Critical barriers to exploring this topic include lack of comprehensive data and methods. The
United Network for Organ Sharing (UNOS) database has many limitations that prevented
researchers from studying the effects of distance on post LT survival. Elements common to most
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forms included primary diagnosis, medical condition at time of transplant, functional status, pretransplant serology, and transplant procedure type. Pre-transplant risk factors included factors
such as portal vein thrombosis and previous abdominal surgery for liver transplants. Elements
common to the Transplant Recipient Follow-up (TRF) forms included patient status and cause of
death, graft status and cause of graft failure, rejection episodes, and biological/anti-viral and
immunosuppressive medications. Patients’ place of residence and lab results were not available
in the detail that was captured here, especially with regard to distance.

Since the UNOS database does not contain patient address information, this could be the reason
behind the lack of published data on the topic of patient distance. The preliminary data consisted
of 627 patients who were transplanted at Tampa General Hospital (TGH) between 1996 and
2009. Patients were excluded if they underwent multiple organ transplantation (n=37), had
fulminant hepatic failure (n=20), died the day of transplant (n=5), or relocated temporarily to be
closer to the transplant center (n=46). An additional 194 patients who were transplanted between
2009 and 2012 were added to the initial 627. None of the previous studies had attempted to use
AFT models which, although more restrictive due to the distribution assumption, could prove to be
more powerful when the underlying distribution was known or could be reasonably estimated.
The proposed method for identifying change points in the hazard function was an extension to
recent methods described in journal articles (Liu et al., 2008; Matthews & Farewell, 1982; Zucker
& Lakatos, 1990), adapted and specifically designed to dichotomize continuous variables and
locate change points in the hazard. The improvements to scientific knowledge offered by this
study were a more comprehensive dataset and the extension of newer statistical methodology.

th

The LT program at TGH began in 1996 and is currently the 9 largest LT program in the country
th

and the 4 busiest transplant center in the nation. Data for this analyses was derived from TGH
electronic medical records called Electronic Privacy Information Center (EPIC), transplant
databases including Organ Transplant Care Platform (OTTR), Chartview (previous electronic
record system at TGH which has been replaced by EPIC), flowcharts, and the United Network for
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Organ Sharing database containing TGH transplant data. Those who relocated to temporary
housing near the transplant center were excluded from the study. The objective is to study the
distance between the patients’ permanent residence in relation to the transplant center, as it
pertains to difficulty with post LT care, HCV treatments, compliance with tests and other factors.
Including patients that came from out of state, relocated near TGH, and left early post-transplant,
transferring their care to other centers would invalidate and bias this study.

Data at the time of transplant were extracted from Chartview, EPIC and OTTR then entered into
Microsoft Excel for Windows (Microsoft Corporation, Redmond, WA) and statistical analysis
conducted using SAS 9.3 (Cary, NC: SAS Institute. Inc) and R (R Development Core Team
(2010). R: A language and environment for statistical computing. Vienna, Austria: R Foundation
for Statistical Computing. Retrieved from http://www.R-project.org).

This study is invaluable for the LT community, as it pertained to how outcomes could be improved
in LT patients. In this study of distance from the LT center, utilized more patients at longer
distances, followed for a longer period post LT, and is specific to those patients receiving LT only,
since the follow-up process for other organs was different. Distance was calculated using SAS
9.3 using an algorithm based on zipcodes (Distance_from_home
=zipcitydistance(zipcode,TGHzip)). Methods used to establish a distance cutoff in this
study were data driven and therefore more accurate than the vague dichotomization of rural vs.
urban used by Park et al. (2012; 2011) and Axelrod et al. (2008). In addition, I studied an adult
population, which constitutes the majority of LT patients. Pediatric patients were not transplanted
at TGH at the time of this study. Furthermore, the distance portion was unique in that patients
relocating temporarily to be near the transplant center for purposes of receiving a transplant were
excluded, as well as those receiving multiple organ transplants and those with Fulminant Hepatic
Failure (Status 1). Therefore, this significant bias present in other studies was eliminated.
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My methods included Kaplan-Meier curves, Cox PH, AFT, and restricted cubic splines. Newer
methodologies implemented included the use of AIC/ML to best determine the cutoff point, Monte
Carlo to determine change points associated with distance, an additional component for
dichotomizing distance and their significance were also implemented.

1.5 Contributions from this Dissertation
This dissertation proposes a more general form of the approach taken previously (Liu et al., 2008)
which accommodated dichotomization of a continuous variable, which in this case was distance.
The general framework

 



exp    ,   #  

allowed for  to include a change point in time  as well as a distance cutoff c. While extension

three (described in more detail below) allowed for a distance contribution after the cutoff point c,

extension four was more flexible allowing for an incremental distance effect after the point c.
While maximizing the partial likelihood gave us parameter estimates, the Cox PH model could not
attach any measure of statistical significance to the necessity of change points  and c. I was

interested in knowing if these effects were different from 0 and whether they were actually

necessary and significant in the model. The purpose of the MC method was to determine the
necessity and significance of  and c in the model.

In this model there was a higher dimension for  and  than in the models of Liu et al (2008),

which complicated many aspects of the computation. As examples, I noted that ¤k was now a

matrix and a two dimensional grid search was now required to establish  and c. Furthermore, I
no longer had the special structure in >  ,  which allowed evaluation only at observed event

times. The approach proposed here required evaluation at all event times in some chosen grid of
values, since Z no longer factored out as it did before (Liu et al., 2008).
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In addition, the maximum likelihood criterion (via AIC) was applied to repeated Cox PH models
while adjusting for multiple covariates, to determine the best dichotomization point for distance.
This method was not standard.

Also, this study followed patients up to 5 years post LT, which is 2 years longer than what is used
for accreditation of centers and longer than what was previously studied in the literature. I also
used a significantly larger population than previous studies.

Change point hazard functions may have implications in health care policy decisions in the future.
With an enhanced understanding of the changes in LT recipient population mortality rates one
can identify gaps, seek solutions, improve performance, and ultimately, better the public’s health.
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Table 2: Contributions from this Dissertation

Existing
Approaches

Methods /
technical

Use the change point
equation proposed by
Liu et al (Liu et al.,
2008)

Dichotomization
criterion

Application

Use KM and Cox PH to
analyze survival data

Studied a maximum of
3 years post-transplant

New in my Dissertation
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Higher dimension for  and . ¤k is now a
matrix and a two dimensional grid search is now
required.
Drop , if distance Z does not have a
"throughout" effect, but only an effect after a
certain time .
Change  p  to    which is a
statistically equivalent model (if is retained)
but has a more natural interpretation in this
database. If is not retained in the model, then
this change means there is only a distance
effect for times greater than .
Dichotomize the distance Z, replacing it by
I(Z>c), and then extending the approach in Liu
et al (2008) to estimate the change point c in
addition to .
Replace Z by max(Z-c,0), the positive part of Zc. This gives another way of saying that there is
no distance effect for distances less than c, but
allows the effect to increase for larger
distances.
Use ML criterion (via AIC) while adjusting for
multiple covariates to determine the optimum
cutoff point for distance

Use AFT in addition to the standard methods
Study 5 years post-transplant, 2 years longer
than what is used for accreditation of centers.
Use a larger patient population than previous
studies.
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Chapter Two
Methods

2.1 Data Source
This study was approved by the University of South Florida Institutional Review Board. It
involved a retrospective review of 821 adult patients who underwent orthotropic liver
st

th

transplantation at TGH between January 1 1996 and September 25 2012. All transplants were
from deceased donor sources. Patients were identified consecutively since the program’s
inception, and data were complete on all patients. Data were obtained from Electronic Privacy
Information Center (EPIC), Organ Transplant Care Platform (OTTR), Chartview and transplant
flowcharts. In addition, United Network for Organ Sharing (UNOS) database containing TGH’s
transplant data was accessed as needed to ensure complete information. Patients were
excluded if they underwent multiple organ transplantation, had fulminant hepatic failure (Status
1), died the day of transplant (n=5), or relocated temporarily to be closer to the transplant center
(n=42).

This study considered random censoring from only administrative censoring 5 years post LT.
Survival time was independent of censoring, satisfying this assumption necessary for the model.

2.2 Etiology Grouping
Etiology was condensed into the following three categories: 1) Nonalcoholic steatohepatitis

(NASH) and Alcohol, 2) HCV/HCC, and 3) HBV/ primary biliary cirrhosis (PBC) / primary
sclerosing cholangitis (PSC)/ Other. In preliminary analyses, there was a statistically significant
difference in survival across these three groups. Log-rank, Wilcoxon, and the likelihood ratio test
yielded significant p-values (less than 0.0001). Patients with NASH and alcohol related liver
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disease had the best survival, while those with HCV and HCC had the worst survival due to
reinfection of the graft by HCV and the recurrence of HCC in the cancer patients.

PBC is a disease of the liver that affects the bile ducts within the liver. Inflammation destroys the
bile duct which causes bile to remain in the liver, resulting in injury and damage to the liver cells,
causing cirrhosis or scarring of the liver. Cirrhosis leads to scar tissue in the liver so the liver
loses its ability to function. Cirrhosis also prevents blood from the intestines from returning to the
heart. PSC also affects the bile ducts causing inflammation and subsequent obstruction of bile
ducts both at the intrahepatic and extra hepatic level. This inflammation hinders the flow of bile to
the gut, causing cirrhosis of the liver, liver failure and liver cancer (Maggs & Chapman, 2008).
Since these two diseases were related they were grouped together. Hepatitis B was very rare
among this group of patients (n=3) so it was grouped with PSC and PBC along with other rare
diseases.

HCV infection is a major risk factor for HCC, and 73% of HCC patients in my dataset also had
HCV. There was an incubation period of 20-30 years in most HCV related HCC cases and HCV
infection usually resulted in HCC via cirrhosis, although the possibility of direct carcinogenic
effects of HCV have also been suggested (Di Bisceglie (1997).

Nonalcoholic steatohepatitis (NASH) is a rare complication of obesity with laboratory and
histological features indistinguishable from alcoholic hepatitis (Eriksson, Eriksson, & Bondesson,
1986). Both of these involve a fatty liver. Therefore these 2 diseases were grouped together.

2.3 General Modeling and Methodology
As primary variables of interest, distance from the transplant center adjusting for the presence of
HCV and HCC was studied. Distance was calculated from the patient’s original home at the time
of referral to the transplant center in Tampa, FL using SAS 9.3 using an algorithm based on zip
codes (Distance_from_home =zipcitydistance(zipcode,TGHzip)).
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Survival analysis was performed using Kaplan Meier (KM), Cox Proportional Hazards (Cox PH),
and Accelerated Failure Time (AFT) methods. Logistic regression (LR) analysis was used to
predict outcome (failed vs. not) 1 year post-transplant. Patients transplanted after September 25,
2011 were excluded from the LR analysis since they did not have a yearlong follow-up before the
end of the study on September 25, 2012 (n=739). Continuous descriptive data were presented
as mean ± standard deviation, while categorical data were summarized as frequencies.

The Cox PH model was chosen because it is semi parametric with minimal assumptions. Also,
with the Cox PH the effect of distance and HCV/HCC could be reported as hazard ratios that are
easy to interpret. Patients were censored five years post-transplant. The five year period was
more than enough to measure the utility of LT. Long term survival measured beyond five years
could be affected by patients’ co-morbidities, de novo post LT malignancies, non-adherence, loss
to follow-up, suicides, accidents, cardiovascular disease, transfer of patients to other centers
whom assume their long term care (loss to follow-up), and other causes. Neither UNOS, nor the
Scientific Registry of Transplant Recipients (SRTR), nor the Center for Medicare Services (CMS),
holds transplant centers accountable for survival beyond three years. This is the yardstick that
was used for maintaining accreditation and comparing centers.
Logistic regression (LR) analysis was the weakest method used, since it disregarded the length of
the patient’s survival post LT and carried the disadvantage that each time point of interest
required a separate model. Also, LR was run on a reduced dataset of 739 patients for one year
post LT analysis. Distance models were evaluated with a Cox PH multivariate regression model
to adjust survival for HCV and HCC, which were associated with patient mortality. The same
conditions applied for AFT. The standard for statistical significance was a p-value less than or
equal to 0.05. Analysis was conducted including and excluding patients who died within the first
30 days post LT (n=22) to determine if there were any effects on the model by excluding these
patients.
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2.3.1 AIC/Maximum Likelihood Approach
In order to choose the best threshold value for dichotomizing distance from transplant center for
predicting outcome (failed within 5 years from transplant), the following approach was taken.
Akaike’s Information Criterion (AIC) is a measure of the goodness of fit of an estimated statistical
model (Bozdogan, 1987) and it is an operational way of trading off the complexity of an estimated
model against how well the model fit the data. Plots of the AIC from Cox PH models vs. all
possible cutoff values c, were computed and plotted on a graph.
Â  2Ã - 2ln 

Ã  number of parameters in model
L = maximized log-likelihood

Smaller AIC values indicate a better fit. If the number of parameters was constant in this
approach, AIC would be equivalent to twice the negative log-likelihood, apart from a constant. I
adjusted for multiple covariates using the AIC criterion to detect a change point attributed to
distance and ensured that this cutoff remained consistent regardless of the number of covariates
included in the model. Since I did adjust for multiple covariates, this approach was different from
using the likelihood ratio criterion.

2.3.2 Restricted Cubic Regression Splines
Restricted cubic regression splines are a useful tool in exploratory data analysis since they allow
the detection of unknown functional relationships between continuous covariates such as
distance and the response variable, survival time in the Cox PH model (Durrleman & Simon,
1989; Heinzl, Kaider, & Zlabinger, 1996). They were employed here to explore the potential nonlinear relationship between distance from LT center and the length of survival post LT. The RCS
macro (H. Heinzl & Kaider, 2007) was used and modified for use with this data set so the splines
would reveal information about the relationship between distance as a continuous variable and
survival.
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The expression for a restricted (or natural) cubic spline function with k knots,
by
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C(u) has continuous first and second derivatives, is linear in u for u<t1 and u>tk (linear in the tails),
and is a linear function with regard to the k parameters

 , * , * , … . BLM .

(Heinzl & Kaider, 1997)

Confidence bands (1-α) are often helpful in interpretation and those are given by
'jÄ] £ , 'ÅKK £ %  ' $Æ Ç #Æ Æ */M

where '   ' , '* , É* , … ÉBLM 2 , Æ  1, £ , * £ , … BLM £ 2 , V is the large sample covariance
M
matrix for ' , and n  bK,*LW
is the (1-α) quantile of the b M distribution on p degrees of freedom.

When p is set to the number of covariates this method yields Scheffe-type simultaneous

confidence bands, and when p is set to 1 it yields standard point wise confidence bands (Hess,
1994). The number of knots was pre-specified. In the literature it was suggested that three to
five knots would usually suffice (Durrleman & Simon, 1989; Heinzl et al.,1996; Hess, 1994)
although I experimented with a larger numbers of knots too. These knots were placed at
quantiles of the observed distribution of u, near but not at the extremes and roughly uniform over
the quantiles. The result of fitting a cubic spline to the data set was usually insensitive to the
location of knots unless they occurred in an extremely non-uniform way over the covariate space
(Durrleman & Simon, 1989; Heinzl et al.,1996; Hess, 1994).
Let n=821, then the data could be denoted by (Ê> , Ë> , ¦>  for i=1, …n where y was the survival time,
s was the censoring variable where 1 indicated a death and 0 meant the patient was censored

and still alive, and z denoted distance from the transplant center. The hazard using Cox PH was
 ; ¦>  



 exp ¦>  and β was estimated using partial likelihood requiring no further

assumptions about the unknown baseline hazard function
function with respect to Z was

LHRZ  log

Ð2;|
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. The log hazard ratio (LHR)

It was assumed that a unit change in distance Z had the same effect on the patients’ log hazard
ratio across the entire range of Z but to explore the nature of LHR(Z) more flexibility was needed.
Hence  ;  



 expÒ which yielded ZÓ  log

0, f(Z)=0 for Z=0. Then ZÓ  log
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Since in this scenario it was not meaningful to report hazard ratios relative to a distance of 0 but it
was of great interest to report them in relation to a specific mileage point of 180 miles, the LHR
function for a given reference value m was
=  ; 
 Ò - ÒÖ Ô  - Ö 
ZÓÕ   log
= ; Ö

* 

BLM

- Ö  5 ( (  - ( Ö
(8*

Once β1, θ1…θk-2 were fitted the reference value m could be changed and that only involved a
shift in the axis. Confidence intervals were also computed and displayed on the graph (Heinzl &
Kaider, 2007).

2.3.3 Estimating Change Points Using Monte Carlo
Given that Firozvi et al. (Firozvi et al., 2008) found no significant distance effect one year post LT,
one of the goals was to search for change points in the hazard function that could be attributed to
distance in a five year period. I was also interested in the time change point over the five year
period. It was possible that the distance effect was not present initially but became evident later
on in the patient follow-up (see dichotomizing at c in extension three below). It was also possible
that beyond that point, the distance effect was incremental (increasing distance effect in
extension four below). Identifying change points in a hazard function is important in survival
analysis and I was particularly interested in the Monte Carlo approach used by Liu et al (2008).
This method gave a legitimate p-value for the test for the existence of a change point at an
unspecified location (known only to belong in a certain set).

The hazard function proposed by Liu et al. (2008) was specified with one change point in the
hazard function as
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where λ t was an unspecified baseline hazard function,  > 0 was the change-point parameter,

θ was the magnitude of change after the change point, β was the throughout distance effect on

the hazard function, Z was a covariate (distance from transplant center) which potentially caused
the non-constant hazard, η were the coefficients and X(t) were other risk factors that I adjusted
for in the model (HCV and HCC). Using this model I determined the presence of change points
in the hazard , as well as the change point in the distance effect, c.

Liu et al. (2008) developed this method to give a legitimate p-value for the test of the existence
of a change point at an unspecified location. I was using this method in a very unique way to first
dichotomize distance at some value c, reducing it to a binary variable. Next I chose a value of

time  such that the distance effect was only observed for times greater than . The values of c
and  could both be considered change points and the approach in Liu et al. (2008) could be

used to simultaneously choose both of them after their methods were suitably generalized.

In the simulation performed by Liu et al. (2008) the authors performed 1000 runs and in each run
the thresholds were calculated using 10,000 Monte Carlo resampling samples. Sample size was
set to 200-300. It was established that the Monte Carlo resampling-based methods approximated
the distribution of the maximal score tests very well. Accuracy of the approximation and power
increased with sample size, and instability of the variance was noted when there were few failure
events. These authors also established that the maximum normalized score statistic was less
sensitive in the detection of a change point than that based on the non-normalized score, under
all alternative hypotheses that they considered. The maximum normalized score statistic was
also more conservative under the null hypothesis.

2.4 Methodological Development Proposed for this Dissertation
The extension to this methodology was in the form of a more complicated null hypothesis than the
one in Liu et al. (2008). As stated above, distance was dichotomized at some value c, reducing it
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to a binary quantity rather like the treatment assignment in Liu et al. (2008). In addition, a value
of time  was chosen such that the distance effect was only observed for times greater than .
The values of c and

 were both considered change points, and the Monte Carlo approach was

used to simultaneously choose both of them.

The general form of the extended model was

 



exp    ,   #  

for parameters , #, . This model was linear in  and # for fixed . The parameter  contained
the nonlinear parameters  which represent change points in time and c which represented the
dichotomization point for distance which was the mileage point beyond which distance had an
effect on survival.  ,  and X(t) were functions of covariates, which could be time-varying

covariates. In this particular dataset X(t) was not time-varying but the model could be applied in
the scenario where X(t) included time-varying covariates. Distance in my model was part of

  ,  which made the model in Liu et al. a special case of this extended model in which   

and   ,    p .

th
Let >    F> p , >  1 be the count of failures on the i subject at time t, >    F>   be

the at-risk indicator, and   inf ? ; JyF !   0C. For a trial with n subjects, the partial likelihood
for the unknown parameters (, #,  based on the observed data would be
9

 , #,   + 
>8*



exp  >  ,   #  >  
.  
 exp  (  ,   #  (   >

9
 ∑(8* ( 

The goal was to test the null hypothesis Z :   0 using the score function
&k , #,  


t, #, 


where t represented the logarithm of the partial likelihood. Let # be the maximum partial

likelihood estimate of # under the null hypothesis. The variance estimator of &k 0, #,  under Z
was denoted by #,  (Fleming & Harrington, 2011); a definition is given later.
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The score functions are given explicitly by
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The corresponding test statistics defined by Liu et al (2008) were

  supÙ |&k 0, #, | and  U  supÙ k  #, 

where k #,  

 Ù
ÚÛ_ ,,
 ,Ù
` 

.

In the work of Liu et al (2008)  is univariate, and consequently #,  is univariate. But in much

of the present work  is bivariate, i.e.,   * , M , so that the score &k , #,  is a 2x1 vector

which can be written as &k , #,   &k* , #, , &kM , #, , and the variance estimate #,  is a

2x2 matrix. Thus I have statistics analogous to the M and M* for each of the components of ,
which I define by

where k #,  
(

(  supÙ |&k 0, #, | and (U  supÙ k  #,  for j=1,2,
3

 ,Ù_
ÚÛ ,
 ,Ù
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(

(

. Motivated by standard results on quadratic forms, I also defined a

test statistic M2p which combines both components of the score vector as follows
MK  supÙ &k 0, #, #, L* &k 0, #, .

The statistic M2p, which is new to this work, is essentially a ‘two parameter’ analog of the statistic
M*, and in my work this statistic is usually referred to as the ‘two parameter score’ or identified by
the acronym M2P, where ‘2P’ stands for ‘two parameter’. In Liu et al (2008) the set  is onedimensional so that the Supremum in their definition of M and M* is a one-dimensional

maximization. However, in much of the present work   , " and the set  is two-dimensional,
which is taken to be a finite grid of time and distance values , ". In computing ( , (U , and MK ,

we maximize over this two-dimensional grid.
B

L* 0,
ª>  
&'k,>    ?>  ,  - ¨  , , #C - ¤k 0, #, ¤
#, ?>   - Þ  , #C%.
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At each fixed point , let  #,   ∑9>8* &'k> &'k>  which reduces to  #,   ∑9>8* &'k>
 in the

univariate case considered by Liu et al (2008). Then /L* #,  is a consistent estimate for the

asymptotic variance of /L_ &k 0, #,  under the null hypothesis. The Monte Carlo null distribution
:

of &k 0, #,  was found by simulating &'k 0, #,   ∑9>8* &'k,> ¶> where ?¶> , ·  1, … , /C were
independent standard normal random variables serving as perturbation factors in the sum.
The values of &'k 0, #,  may be used to obtain Monte Carlo approximations to the null

distributions of the statistics ( , (U , and MK by using these values in place of &k 0, #,  in the
computation of these statistics. That is I computed Monte Carlo replicates of
ª(  supÙ |&'k( 0, #, |,


ª(U  supÙ ÚÛ


' 3 ,,
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ªMK  supÙ &'k 0, #, #, L* &'k 0, #, .
, and 

th

The empirical 100(1-α) quartile of the randomly perturbed maximal score statistics provided the
critical values of nominal level α for the observed maximal score statistics.

The specific extensions I considered were:

1. Dropped

, to indicate that distance Z (dichotomized at 180 miles) did not have a throughout

effect, but only an effect after a certain time .
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2. Changed 
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p  to    which was a statistically equivalent model (if

had a more natural interpretation in this situation. If

is retained) but

was not retained in the model, then this

change meant there was only a distance effect for times greater than . In this model Z was

dichotomized at 180 miles.

 ; ,  
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3. Dichotomized the distance Z, replacing it by I(Z>c), and then extending the approach in Liu et

al. (2008) to estimate the change point c in addition to .

 ; ,  



This fit into the general framework
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4. Alternatively, I replaced Z by max(Z-c,0), the positive part of Z-c. This gave another way of
saying that there was no distance effect for distances less than c, but allowed the effect to
increase for larger distances.
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This also fit into the general framework
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by taking ¿  â ã , #  n,   â ã ,  ,   R
S ,     . Here  - ") 
"
   - ")

max - ", 0.

The additional challenge for extensions three and four is that , , , c and n must be estimated
simultaneously. There are 2 possible approaches to this and we tried both:

The first approach involved the estimation of

, , and n for fixed values of c and . This implied

fitting a standard Cox model for each of c and , which was efficient, particularly since reasonable
initial estimates were used.

Maximizing the likelihoods could be done by standard algorithms, such as simulated annealing,
variants of gradient ascent or algorithms like Nelder-Mead which required only repeated function
evaluations. The log-likelihood function was optimized using the Nelder-Mead algorithm, a
variable metric algorithm (Broyden, Fletcher, Goldfarb and Shanno, 1970), and a simulated
annealing algorithm to estimate , ", , , n* , and nM .

First I used the simplex search algorithm proposed by Nelder and Mead (1965). This method is
very effective for multidimensional unconstrained optimization without derivatives (Price & Coope,
2003). Only function values are used and it is robust but relatively slow. This method performs a

sequence of transformations on the working simplex, defined by n+1 points @ , … @9  ä9 that are
considered as the vertices of a working simplex S. The goal is to decrease the function values at

the vertices. In each iteration of the Nelder–Mead algorithm, the vertex with the worst function
value is removed and replaced with another point which has a superior value. The new point is
obtained by reflecting, expanding, shrinking or contracting the simplex along the line joining the
worst vertex with the centroid of the remaining vertices. If one cannot find an improved point, only
the vertex with the best function value is retained, and the simplex is shrunk by moving all other
vertices toward this value. This process is terminated when the working simplex S becomes
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sufficiently small, or when the function values are close enough. It has been proven to work
reasonably well for non-differentiable functions (Kolda, Lewis, & Torczon, 2003; Nocedal &
Wright, 1999).

A quasi-Newton method which is also known as a variable metric algorithm (Broyden, 1970;
Powell, 1976), that uses function values and gradients to build up a picture of the surface to be
optimized was also used. It was published simultaneously in 1970 by Broyden, Fletcher,

Goldfarb and Shanno (BFGS). Often BFGS may not move away from the initial values of  and "

because the numerically estimated gradient is exactly zero. The log-likelihood is flat as a function
of  and " in the neighborhood of   3.66 and "  180 (see Chapter 3). I anticipated this method

to behave poorly because it was designed for differentiable functions and the log-likelihood in this
case is discontinuous with respect to  and " but the estimates it produced were not different from
the other 2 methods.

Next a variant of simulated annealing (SANN) was used (Bélisle, 1992). Simulated annealing is a
Monte Carlo technique for solving optimization problems. It is a stochastic global optimization
method and since it is random, it may often not find anything better than the initial parameters.
Only the function value is used, it is relatively slow, and was chosen because it works for nondifferentiable functions. This implementation uses the Metropolis function p=p(x,y,t) for the
acceptance probability of the next candidate point y, given the current state x and the
temperature t. By default the next candidate point is generated from a Gaussian Markov kernel
with scale proportional to the actual temperature t. Temperature is decreased according to a
logarithmic cooling schedule (Bélisle 1992, p. 890). A disadvantage is that it depends critically on
the settings of the control parameters and it is not a general-purpose method but can be very
useful in getting to a good value on a very rough surface.

In the frequentist MC approach, the parameter estimates for the covariate effects not associated
with the change point were estimated under the null hypothesis that there was no change point.
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So after the MC approach had demonstrated the necessity for a change point, these parameters
were re-estimated. One potential approach involved simultaneous estimation of all the
parameters, including the change point, by maximizing the partial likelihood and incorporating a
grid search for maximizing over the change point. Another choice was setting the change point
equal to the value which maximized the score statistic and then re-estimating the other
parameters by fitting a standard Cox model as in the example in Section 3.4 of Liu et al. (2008).
The models included both a change point (in time) and a dichotomization point (for the distance).

2.5 Simulation
I conducted a simulation study using the hazard functions in extensions one to four. There were
two types of simulations:
1. Using data that was generated from standard distributions
2. A situation which resembled the actual LT data set.
The purpose of the first simulation was to demonstrate that the methodology worked and that of
the second simulation to determine how the methodology worked with the actual LT data
structure.

2.5.1 Simulation 1
Distance Z was generated from a random uniform distribution on the interval (0, 1) for extensions
three and four and a Bernoulli distribution with a success probability of 0.5 in extensions one and
two, to resemble a dichotomous variable. Two additional risk factors were generated using a
uniform distribution on (0, 1) and an exponential distribution with mean 1. The change point
parameter was set to   0.25 and the distance cutoff to c=50.

For 1000 simulated data sets, critical thresholds based on 1,000 Monte Carlo resampling
samples were calculated for each of the four extensions above. The sample size was set to 200
and 300 for approaches one and two and 600 for approaches three and four. A grid was defined
over the suspected region where the change point  and the cutoff c were suspected to lie. The
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proposed test procedure was implemented searching for a change point over the grid of a time
interval and the distance cutoff range in miles. The simulation results are summarized in tables
31 through 36 where the partial likelihood was maximized over the above stated grid.
The empirical threshold corresponding to a nominal level T was determined by the 1001 - T2æ

quantile of the sample test statistics from 1000 runs of simulations under the null hypothesis. The
average Monte Carlo resampling-based threshold was defined as the mean of 1000 thresholds
found by the Monte Carlo resampling approach.

The results were tabulated in section 3.9.1 to compare the empirical quantiles of the test statistic
based on 1000 simulated data sets with the Monte Carlo resampling thresholds.

2.5.2 Simulation 2
The second simulation effort aimed at resembling the actual situation in the LT data set, with the
goal of determining the level of performance that might be expected of my methods in this
situation.

HCV, HCC and distance from the original dataset were used. Survival times were generated
from the Cox PH model to fit to this data set for each of the hazard functions in extensions three
and four (i.e., using the estimated parameter values and a baseline hazard obtained by
smoothing Breslow’s estimator) with censoring. A piecewise exponential was used to generate
the censoring time and the censoring variable was created by determining which of the two was
smaller. For simulations under the alternative hypothesis, this testing procedure was repeated for
a range of values for β and , and the accuracy of estimation for  and c was recorded.

Since this study involved the estimation of both a change point in time  and a distance cutoff c,
the computations were significantly more complex than those done previously (Liu et al., 2008)

with an appreciable programming effort required. I evaluated this model over a grid of time and
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distance values with the all times considered, not just the event times since distance Z no longer
factors out as it did in the simpler case of Liu et al (2008).
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Chapter Three
Results and Applications

Four extensions to the MC approach were developed as described in the previous chapter. In
this chapter, these models were applied to a specific dataset of liver transplant recipients. In this
retrospective single center study of 821 liver transplant recipients at TGH; Hepatitis C (HCV),
Hepatocellular Carcinoma (HCC), and patient survival were collected in addition to distance from
the transplant center. This methodology allowed us to establish a change point in the hazard
function  as well as a dichotomization point for distance c.

This chapter starts with an introduction of the dataset and the Kaplan Meier curves, Cox
Proportional Hazards, Accelerated Failure Time and Logistic Regression models. Data were
analyzed both including and excluding early deaths (n=22).
Then I proceeded to fit the model introduced by Liu et al. (2008) followed by the four extensions
that I proposed. Lastly, I performed two types of simulations described in section 2.5 above to
illustrate the use and application of this methodology.

3.1 Introduction
3.1.1 General Description of the Data
Recipients included 603 males and 218 females with a mean age of 53.5 (standard deviation 9).
22 patients died within the first 30 days post LT. The analyses were conducted with and without
these patients. Of the 821 patients, 178 died within five years post LT and 643 (78.32%) were
still alive at the five year mark. Hepatitis C (HCV) or Hepatocellular Carcinoma (HCC) were the
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most common reason for patient transplant. Table 3 below outlines the patient characteristics
including and excluding the 22 early deaths.
Table 3: Liver Transplant Recipient Characteristics
All Patients

Excluding Early Deaths

Total (n=821)

n=799

Age (years) mean ± SD

53.48 ± 8.97

53.49 ± 9

Male (%)

603 (73.45%)

587 (73.47%)

Race (Caucasian)

667 (81.24%)

650 (82.70%)

HBV/PBC/PSC/Other

130 (15.83%)

125 (15.64%)

HCV/HCC

470 (57.25%)

459 (57.45%)

NASH and Alcohol

221 (26.92%)

215 (26.91%)

Primary cause of ESLD (%)

Table 4 describes patient characteristics of 2 groups, those who lived within 180 miles and those
who lived beyond this distance. Mean age, gender, race, and transplant etiology were not
significantly different between these groups. 570 patients who were transplanted after February
2002 had MELD scores calculated prior to receiving LT, of which 553 patients were from within
180 miles, and 17 patients were from beyond 180 miles.

The mean MELD score was significantly lower for the distant group (p-value=0.008) but the
prevalence of HCC (p-value=0.23) and HCV (p-value=0.68) were not. It is suspected that the
more severely ill patients with higher MELD scores, who lived further away, did not actually make
it to the transplant stage. Due to the fact that there were 251 patients transplanted in the preMELD era who did not have MELD scores on file and MELD alone was not a significant predictor
of survival using KM (LR p-value=0.1370) and Cox PH (p-value=0.2050), I opted not to adjust for
it in the model. However, MELD score at the time of transplant indicates that the distant patients
were healthier compared to those living within the 180 mile radius (p-value=0.008).
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Table 4: Clinical and Demographic Features of Patients by Distance Category

Mean Age (SD)

Within 180

Beyond 180

miles (n=802)

miles (n=19)

P-value

53.48 (8.99)

53.6 (8.40)

0.9662

Male

590 (73.56%)

13 (68.42%)

0.6157

Female

212 (26.43%)

6 (31.58%)

Gender

Race/Ethnicity

0.9777

Asian

3 (0.37%)

0

Black

49 (6.11%)

1 (5.26%)

652 (81.30%)

15 (78.95%)

Hispanic

64 (7.98%)

1 (5.26%)

Other

22 (2.74%)

1 (5.26%)

22.09 (7.18)

17.35 (8.85)

0.008

120 (14.96%)

5 (26.31%)

0.403

Autoimmune/PBC/PSC

88 (10.97%)

0

Cryptogenic/NASH

94 (11.72%)

2 (10.53%)

42 (5.23%)

0

HCC

98 (12.22%)

4 (21.05%)

HCV

285 (35.54%)

7 (36.84%)

75 (9.35%)

1 (5.26%)

Caucasian

MELD Score at
Transplant (SD)
Etiologies
Alcohol

HBV/Others

HCV and Alcohol

Next I looked at the effects of disease etiology, gender and insurance type separately. Disease
etiology was grouped into three categories and survival differed by etiology as detected by the
KM curves (p-value<0.0001).

3.1.2 Disease Etiology
Differences in survival by disease etiology were significant in the Kaplan Meier curves above
according to log-rank, Wilcoxon and likelihood-ratio tests (p-values<0.0001). NASH and alcohol
patients had the best survival while those with HCV and HCC fared the worst. This phenomenon
was likely due to disease recurrence in these patient populations.
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Figure 1: KM by Etiology All Patients

Table 5 below confirms that HCV/HCC were the deadliest with 131 (27.87%) deaths, followed by
HBV/PBC/PSC/Other with 23 (17.69%) deaths, and NASH and Alcohol had the best survival with
24 (10.86%) deaths.

Table 5: Disease Etiology for Transplant Patients (All Patients)
Summary of the Number of Censored and Uncensored Values
Stratum

Etiology Condensed

Total

Failed

Censored

Percent
Censored

1

HBV/PBC/PSC/Other

130

23

107

82.31

2

HCV/HCC

470

131

339

72.13

3

NASH and Alcohol

221

24

197

89.14

821

178

643

78.32

Total

Next, I repeated the KM for 799 patients who survived past 30 days post LT.
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Figure 2: KM by Etiology Excluding Early Deaths

Table 6: Disease Etiology for Transplant Patients Excluding Early Deaths
Summary of the Number of Censored and Uncensored Values
Percent
Stratum

Etiology Condensed

Total

Failed

Censored

1

HBV/PBC/PSC/Other

125

18

107

85.6

2

HCV/HCC

459

122

337

73.42

3

NASH and Alcohol

215

19

196

91.16

799

159

640

80.1

Total
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Censored

The same pattern of survival by disease etiology appeared when early deaths were excluded
(n=799), with 122 (26.58%) deaths for patients with HCV/HCC, 18 (14.4%) for patients with
HBV/PBC/PSC/Other, and 19 (8.84%) for those with NASH and Alcohol. Differences in survival
by disease etiology were significant according to log-rank, Wilcoxon and likelihood-ratio tests (pvalues<0.0001). In conclusion, NASH and alcohol patients had the best survival while those with
HCV and HCC fared the worst.

3.1.3 Gender Distribution
There were 218 females in the study and 603 males. Although no significant difference in
survival by gender was detected using KM (log-rank p-value=0.0935, Wilcoxon p-value=0.2007,
likelihood ratio p-value=0.0868), I noticed a separation of the curves after the second year post
LT indicating that females had a slightly better survival after the first three years as compared to
males.

Figure 3: KM by Gender All Patients
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On the reduced dataset excluding 22 patients who died in the first month, there were 212 females
in the study and 587 males. Although no significant difference in survival by gender was detected
using KM (log-rank p-value=0.0775, Wilcoxon p-value=0.1641, likelihood ratio p-value=0.0690), I
noticed a separation of the curves after the second year post-transplant indicating that females
had a slightly better survival after 3 years as compared to males. P-values were lower in the
reduced dataset which excluded 22 early deaths indicating more of a gender difference in survival
for that dataset.

Figure 4: KM by Gender Excluding Early Deaths
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3.1.4 Insurance
Insurance was grouped in 4 categories but failed to yield any significant difference in survival as
seen by the log-rank (p-value=0.7596), Wilcoxon (p-value=0.6341) and likelihood-ratio (pvalue=0.8584) tests. This indicated that the insurance did not impact survival post-transplant
even though the literature indicated that there was an effect on access to transplant (Kemmer et
al., 2011).

Table 7: Insurance for All Patients
Summary of the Number of Censored and Uncensored
Values
Stratum

Insurance
Grouped

Total

Failed

Censored

Percent
Censored

1

Medicaid

106

25

81

76.42

2

Medicare

179

29

150

83.8

3

Other

32

8

24

75

4

Private

504

116

388

76.98

821

177

643

78.32

Total

Table 6 above and Figure 5 below indicate that patients on Medicare had the best post LT
survival while those with other insurance had the worst, but these differences failed to yield any
statistical significance.

Figure 5: KM by Insurance for All Patients
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Table 8: Insurance Excluding Early Deaths
Summary of the Number of Censored and Uncensored Values
Stratum

Insurance

Total

Failed

Censored

Percent
Censored

1

Medicaid

103

22

81

78.64

2

Medicare

173

24

149

86.13

3

Other

30

6

24

80

4

Private

493

107

386

78.3

799

159

640

80.1

Total

The same pattern with Medicare patients having the best survival persisted when patients who
died in the first 30 days were excluded but this was not statistically significant. In this subset,
patients with private insurance fared the worst which was rather surprising.

Figure 6: KM by Insurance Excluding Early Deaths
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However, difference in survival by insurance failed to yield any significant difference in survival as
seen by the log-rank (p-value=0.5442), Wilcoxon (p-value=0.4296) and likelihood ratio (pvalue=0.6183) tests but p-values were again lower than those for the KM including early deaths.
From this data it appears that there is insufficient evidence that private insurance leads to any
survival benefit as one might suspect.

3.2 AIC/ML Approach to the Cox PH Model
I began with the AIC approach to the Cox PH model described in the methods in chapter 2. The
eight models displayed in table 9 were fit, all of which pointed to a distance cutoff of 180 miles as
the value which minimized the AIC and maximized the partial likelihood function.
The following were also considered as covariates in the model: creatinine, bilirubin, insurance,
presence of HCV, HCC, etiology, age, and abuse of alcohol. The data suggested a distinct cutoff
value for distance, and that the plots convincingly indicated such a case.
Table 9: AIC Model for the Covariates
HCC

HCV

Etiology

Alcohol

Creatinine

Bilirubin

Age

Insurance

Model 1

√

√

Model 2

√

√

√

Model 3

√

√

√

√

Model 4

√

√

√

√

√

Model 5

√

√

√

√

√

√

Model 6

√

√

√

√

√

√

√

Model 7

√

√

√

√

√

√

√

√

Model 8

√

√

√

√

√

√

√

√

BMI

AIC
2243.238
2244.004
2244.754
2231.950
2218.825
2220.754
2223.990

√

2225.971

The model adjusting for HCC, HCV, etiology, alcohol, creatinine, and bilirubin had the lowest AIC
of 2218.825 indicating that it was the best model for the data. Using this criterion I concluded that
180 miles was the best cutoff point regardless of which covariates I adjusted for. Figure 7 below
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shows distance from the transplant center on the horizontal axis and the resulting AIC on the
vertical axis. It was evident from the graph that the AIC was minimized at 180 miles.

The algorithm was rerun using the reduced dataset excluding deaths within the first 30 days posttransplant (n=22) and the AIC criterion consistently pointed to 180 days as a critical
dichotomization point.

(a) HCV and HCC adjusted only

(b) HCC, HCV, Etiology, Alcohol, CR and Bilirubin adjusted
Figure 7: Using AIC to Estimate Optimal Cutoff
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3.3 Restricted Cubic Regression Spline
The restricted cubic regression spline was employed to detect a potential non
non-linear
linear relationship
between distance as a continuous variable and post
post-transplant
transplant survival. Seven knots were placed
at 1, 7.36, 21.32, 38.60, 87.88
87.88, 174.15, and 267.77 miles to correspond
orrespond to the quantiles.

Figure 8: Restricted Cubic Regression Spline with 7 knots

From the curve above there was insufficient evidence of a distance effect as indicated by the
Wald

(p-value=0.87) for testing the hypothesis that distance ha
had no effect on post LT survival

as a continuous variable. This p
p-value only decreased slightly (0.79) when the restricted cubic
regression spline was fit on the reduced dataset which excluded early deaths (n=799). This
indicated there wass a need to dichotomize distance and establish a cutoff point for distance
beyond which there wass an impact on survival. This lead to suspicion that there was no
throughout effect of distance over the five year period post LT which was the reasoning behind
behin
the second modification to the Monte Carlo approach where β was dropped from the model.
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The restricted cubic regression spline was also run with 5 knots which made no difference to the
significance (p-value=0.9147).
value=0.9147). Using 9 knots (figure 12) at the following
lowing mileage points 2.8, 5.6,
8.9, 16.2, 29.1, 72.8, 114.2,, 145.3, and 196 miles there was still no statistically significant effect of
distance on survival when distance was specified as a continuous variable.

Figure 9: Restricted Cubic Regression Spline with 9 knots

As indicated using the AIC/ML
/ML criterion applied to Cox PH in figure 10,, 180 miles was the best
cutoff point regardless the other covariates I adjusted for. The KM for distance dichotomized at
180 miles is presented in the next sectio
section.
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3.4 Kaplan Meier
The KM plot for this dichotomization is shown below in figure 10, and p-values for the log-rank (pvalue=0.0049), Wilcoxon (p-value=0.0077) and likelihood ratio (p-value=0.0154) indicated that
survival was improved for patients who had to travel less than 180 miles to the transplant center
as opposed to those who lived more than 180 miles away.

Table 10: Dichotomizing Distance at 180 Miles for All Patients
Summary of the Number of Censored and Uncensored
Values
Stratum

Distance

1

within
180

2

beyond
180

Total

Total

Failed

Censored

Percent
Censored

802

169

633

78.93

19

9

10

52.63

821

178

643

78.32

From table 10 above I noticed that 21% expired among those living within 180 miles while that
increases to 47% for those living over 180 miles from the transplant center. In figure 13 below, it
was evident that the survival curve dropped faster for those living beyond 180 miles. It remained
steadily below that for patients living within the 180 mile radius indicating impaired survival at
longer distances.

Table 11: Dichotomizing Distance at 180 Miles Excluding Early Deaths
Summary of the Number of Censored and Uncensored
Values
Stratum
1
2
Total

Distance
within
180
beyond
180

Total

Failed

Censored

Percent
Censored

780

150

630

80.77

19

9

10

52.63

799

159

640

80.1
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Figure 10: KM at 180 miles

3.5 Cox Proportional Hazards
The Cox PH model below with the 180 mile dichotomization point for distance, adjusted for HCV
and HCC, was statistically significant according to likelihood ratio, Score and Wald p-values (all
less than 0.0001). The hazard ratio indicated that patients living beyond 180 miles from the
transplant center had 2.68 times the death rate compared to those living within 180 miles after
adjusting for HCV and HCC (p-value=0.0040). Breslow’s estimator was used to handle ties.

The Cox PH model was
>





 exp?0.25 Z ç/tÊ>  0.80 Z ç/tÊ>  0.95 éç => - 0.99 £/.6y 180C
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Table 12: Cox PH for 180 Mile Dichotomization
Analysis of Maximum Likelihood Estimates
All Patients (n=821)
Parameter

DF

P-value

Excluding Early Deaths (n=799)

Hazard Ratio

P-value

Hazard Ratio

HCC only

1

0.6011

1.279

0.2884

1.660

HCV only

1

<.0001

2.227

<.0001

2.639

Both HCV and HCC

1

<.0001

2.577

<.0001

3.136

Distance beyond 180

1

0.0040

2.681

0.0009

3.145

P-values decreased when patients who died within the first 30 days post-transplant were
excluded as noted in table 12 above. All of the 22 patients excluded for early death resided
within the 180 mile radius.

Figure 11: Survivor Function for Cox PH
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Separate Cox PH models were fit for patients with HCV and HCC respectively. The effect of
distance was more pronounced in patients with HCV (HR of 3.72 for 434 HCV patients vs. 2.5 for
total 821 patients). The distance effect was even stronger in patients with HCC (HR of 5.24 for
134 HCC patients).

Figure 12: KM Curve for HCV Patients

To assess the fit of this model I first looked at deviance residuals. They were symmetrically
distributed around 0 and had a standard deviation of approximately 1.0. Residuals were positive
for patients with shorter survival time than expected and negative for patients with longer survival
times than expected. Very low or very high values suggested that the patient may be an outlier
and therefore in need of attention. Below in figure 13, the residuals were plotted against the
covariate distance (continuous variable), and unusual patterns would have suggested features of
the data that had not been adequately fitted by the model. This dataset contained censored data
so caution was exercised because censoring could produce striking patterns that don’t
necessarily imply any problem with the model.
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Figure 13: Graph of Deviance Residuals by Distance as a Continuous Variable

A clear disjunction between the two groups of observations was noted.. The cluster of points
toward the bottom were
re all censored observations, while the more widely dispersed points in the
upper portion of the graph we
were uncensored observations.

Covariate-wise residuals including Schoenfeld residuals, weighted Schoenfeld residuals and
score residuals all had a separ
separate
ate residual for each covariate for each patient. They also sum to
approximately zero in the sample. However Schoenfeld residuals were
re not defined for censored
observations. Since distance wa
was a dichotomous variable,
e, the graph for the residuals was
wa not
very informative and therefore was omitted.

Influence statistics were computed to detect whether any particular patient would change the
results if it were removed from the model (Collett, 2003). Influence
nfluence on the model as a whole is
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measured by the likelihood displacement (LD) statistic which detects how much the
th log-likelihood
multiplied by two, would change
ange if the individual patient wa
was
s removed from the sample. LD was
plotted below in figure 14 against distance
distance, and since all values were
re relatively small I concluded
that there were no influential patients who needed to be revisited
revisited.

isplacement Against Distance to Look for Influential Patients
atients
Figure 14: Likelihood Displacement

Another method used to check the proportional hazards (PH) assumption was
s to look at the
cumulative residuals using the Assess statement and ph option in the proc phreg function
(Gharibvand, 2008).
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Figure 15: Checking the PH Assumption for Patients with HCC

A plot of the cumulative martingale residuals against the values of the 5 year survival and a pvalue of a Kolmogorov-type supremum test based on a sample of 1,000 simulated residual
patterns are presented.

The plot in figure 15 displays the observed cumulative martingale residual process for survival
together with 20 simulated realizations from the null distribution. It is obvious that the observed
process is typical compared to the simulated realizations. Also, some of the 1,000 simulated
realizations have an absolute maximum exceeding that of the observed cumulative martingale
residual process. Both the graphical and numerical results indicate that a transform is not
deemed necessary in the model.

59

Figure 16: Checking the PH Assumption for Patients with HCV

Figure 17: Checking the PH Assumption for Patients with Both HCV and HCC
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Figure 18: Checking the PH Assumption for Distance Beyond 180 miles

Table 13: Supremum Test for Proportional Hazards Assumption
Supremum Test for Proportional Hazards Assumption

Variable

Maximum
Absolute

Pr >
Replications

Seed

Value

MaxAbsVal

HCC only

1.0828

1000

19

0.18

HCV only

0.9383

1000

19

0.498

Both HCV and
HCC

0.8996

1000

19

0.471

0.656

1000

19

0.585

Distance
Beyond 180

Based on table 13 and figures 13-18 above, I concluded that there was no serious violation of the
proportional hazards (PH) assumption. Since the p-value for all covariates exceeded 0.05, I am
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95% confident that there was no relationship between residuals and time. This also confirmed the
previous conclusion that the PH assumption was not violated and they were no time-dependent
covariates. Therefore, I did not need to do any further stratification.

In the literature, the Cox PH model was the overwhelmingly favored method for regression
analysis of survival data. This method required no assumptions about the shape of the
distribution of survival times, allowed for time-dependent covariates, could be used with both
discrete and continuous-time data, could stratify on categorical control variables and could be
extended to non-proportional hazards. However, one cannot test hypotheses about the shape of
the hazard function so I resorted to another method known as the accelerated failure time model.

3.6 Accelerated Failure Time Model

An AFT model for the 180 mile distance cutoff was used assuming a Weibull distribution. Other
distributions were fit, but Weibull was the best for the LT data. Since the underlying distribution of
survival time conditional on the covariates was estimated to be Weibull with σ=0.7, this indicated
that the hazard was increasing at a decreasing rate. The survivor function was

&>    exp h- > 6 LM.êë).ê ìíí )*.MM ìí`)*.î ïÄ2æL*.ë ð>®2_Å9;ò7_*ó %

*.ë

l

where HCV, HCC, Both and Dist_under_180 were all indicator variables that determined whether
or not the condition was present.

The log survival became

log F  2.75 - 0.37 Z - 1.22 Z - 1.43 cç =  1.50 õ·Ë ö/"6 £/.6y 180
 IH
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Therefore all other covariates held constant, living within 180 miles increased survival by
1.5

e =4.48 units. The ‘mean’ survival time in patients living within 180 miles was estimated to be
4.48 times longer than that in the group living beyond 180 miles after controlling for HCV and
HCC. The hazard function was illustrated in figure 19 below.

Table 14: AFT Model with Weibull Distribution 180 Mile Dichotomization All Patients
Analysis of Maximum Likelihood Parameter Estimates
95% Confidence
Parameter

Standard Error

P-value

DF

Estimate

Limits

Intercept

1

2.75

0.55

1.67

3.83

<.0001

HCC only

1

-0.37

0.72

-1.77

1.03

0.6060

HCV only

1

-1.22

0.28

-1.77

-0.66

<.0001

Both HCV and HCC

1

-1.43

0.37

-2.15

-0.71

<.0001

Distance under 180

1

1.50

0.53

0.46

2.54

0.0046

Scale

1

1.52

0.11

1.33

1.74

Weibull Shape

1

0.66

0.05

0.57

0.75

Table 15: AFT Model with Weibull Distribution 180 Mile Dichotomization Excluding Early Deaths
Analysis of Maximum Likelihood Parameter Estimates
95% Confidence
Parameter

DF

Estimate

Standard Error

Intercept

1

2.56

0.44

1.70

3.42

<.0001

HCC only

1

-0.62

0.57

-1.73

0.50

0.2790

HCV only

1

-1.16

0.25

-1.64

-0.68

<.0001

Both HCV and HCC

1

-1.37

0.31

-1.98

-0.76

<.0001

Distance under 180

1

1.36

0.42

0.54

2.18

0.0012

Scale

1

1.19

0.09

1.03

1.37

Weibull Shape

1

0.84

0.06

0.72

0.97
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Limits

P-value

By excluding early deaths (n=22) the estimators became more precise with tighter confidence
intervals, and the p-values
values decreased giving a more precise model.

Figure 19: Hazard Function

The Cox-Snell residuals we
were defined as

. These were
re always positive and

when the model wass correct they follow
followed an exponential distribution with parameter λ=1. In
order to evaluate this graphically I computed the KM estimator of the survivor function, and
plotted that against the residuals e. The resulting graph was expected to be a straight line which
passed through the origin with a slope of 1 (see Figure 20).
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Figure 20: Residual Plot (Weibull Model)

Figure 21: Weibull Probability Plot

The estimated cumulative d
density function,, a line representing the maximum likelihood fit, and
point wise parametric confidence bands were plotted in the body of figure 21.. The values of rightright

65

censored observations were plotted along the bottom of the graph (Kay & Kinnersley, 2002). All
the events fell within the 95% confidence bands indicating a good fit for this model.

Next I fit the same model using the exponential and lognormal distributions and it was evident
that the fit was not as good (figure 22 and 23).

Figure 22: Exponential Probability Plot
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Figure 23: Lognormal Probability Plot

3.7 Logistic Regression
LR model is useful in predicting dichotomous outcomes, in this case, whether the patient is dead
or alive at 1 year post-transplant. Patients transplanted after the time period (September 25,
2011) were excluded from the study (n=82) because they had not yet received one year of followup. Distance models were computed, adjusting for HCV for the cutoff of 1 year post LT. It was
established that at a 180 mile distance cutoff, survival was affected (p-value =0.0246) (Table 15).
The odds of death 1 year post LT were 3.4 times higher for patients beyond 180 miles, compared
to those within. When the model was rerun excluding early deaths, the odds of death 1 year post
LT increased to 4.57 compared to those who lived within the 180 mile radius. However, LR
discarded valuable information by ignoring the length of patient survival and by reducing
outcomes to a dichotomous variable (dead/alive) at a particular time point. It was also computed
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on a reduced dataset of 739 patients compared to the Cox PH and AFT models which were able
to utilize all 821 patients in the entire study group.

A total of 739 patients were included in the study and the model was adjusted for the presence of
HCV alone. This was done, as opposed to both HCV and HCC, to avoid non-convergence

issues. Assuming N>2 represents the probability that individual i had an event at time t, conditional
on the fact that an event had not already occurred to that individual. When distance takes on a
value of 1 for within 180 miles and 2 for beyond 180 miles the model can be written as
log R

N>2
S  -1.652 - 0.40 Z>2 - 0.62 õ·Ë ö/"6>2
1 - N>2

Table 16: Logistic Regression 180 Mile Dichotomization All Patients
Analysis of Maximum Likelihood Estimates
Parameter

Estimate (SE)

Intercept

Odds Ratio

95% Wald CI

P-value

-1.65 (0.28)

<.0001

Hepatitis C

No

-0.39 (0.13)

0.459

0.275

0.765

0.0028

Distance

1: under 180

-0.61 (0.27)

0.292

0.1

0.854

0.0246

The same model was rerun excluding patients who died in the first 30 days post LT. A total of
722 patients were included in the model. The resulting model was presented below.
log R

N>2
S  -1.852 - 0.56 Z>2 - 0.76 õ·Ë ö/"6>2
1 - N>2

Table 17: Logistic Regression 180 Mile Dichotomization Excluding Early Deaths
Analysis of Maximum Likelihood Estimates
Parameter

Estimate (SE)

Intercept

Odds Ratio

95% Wald CI

-1.85 (0.29)

P-value
<.0001

Hepatitis C

No

-0.56 (0.16)

0.323

0.174

0.600

0.0003

Distance

1: under 180

-0.76 (0.28)

0.219

0.073

0.654

0.0066
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I computed LR models at 3 and 5 years post LT at multiple incremental groupings of 30 miles [30,
60, 90,120,150, 180, and so on], of 60 miles, 90 miles, 120 miles, 150 miles, 180 miles, and 240
miles. Models of distance cutoffs vs. the rest of the patients (30 miles vs. the rest; 60 miles vs. the
rest, and so on, up to 240 miles) were also run. None of these LR models was able to pinpoint a
distance vs. outcome effect, due to the use of a markedly limited dataset from extensive
censoring.

3.8 Monte Carlo Approach to Change Point Detection
Initially I used the method developed by Liu et al. (Liu et al., 2008) with distance dichotomized at
180 miles from the transplant center. Patients were dichotomized according to the distance from
transplant center (0: within 180 miles, 1: beyond 180 miles) and KM curves were presented in
figure 8. KM curves crossed early on and survival for the distant group remained steadily below
that of patients living within the 180 mile radius. This indicated that distance may not affect
survival immediately after transplant but may begin at a later point in time. It was also possible
that the distant patients were in the hospital for longer and the distance effect did not begin until
after their hospital discharge. This was a factor that I investigated further using Cox PH models
that included change points.

In its general form the hazard function was specified as

 



exp    ,   #  

where Z represented distance,  contained the nonlinear parameters  which was the change
point in time and c the dichotomization point for distance, # contained the coefficients

for

distance and n for the presence of Hepatitis C and HCC, and X(t) contained indicator variables for

Hepatitis C (HCV) and Hepatocellular Carcinoma (HCC).

Let

0 if the patient did not have HCVr
*  o
1 if the patient had HCV
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0 if the patient did not have HCCr
M  o
1 if the patient had HCC
3.8.1 Original Hazard with One Change Point
I was interested in testing the existence of a change point associated with the distance cutoff that
was determined using the AIC (180 miles) over the time period of 0-5 years post liver transplant.
When distance Z was already dichotomized at 180 miles the hazard function above could be
simplified to

 ; ,  



 exp?   p C  #$.

Using the Monte Carlo approach by Liu et al., distance Z was defined as 0: within 180 miles and
1: beyond 180 miles, while adjusting for HCV (1: yes; 0: no) and HCC (1: yes; 0: no). The pvalues were 0.566 and 0.235 and the overall 5 per cent significance level thresholds were 3.57
and 8.04 for M and M*, respectively, based on 10,000 resampling samples. The thresholds were
presented by the horizontal lines in the plot. The potential change point locations in terms of
achieving the maximal score statistics were at 3.622 and 4.186 years post-transplant for
|&k #; | and k #;  respectively.

Table 18: Change Point Detection Using 180 Mile Dichotomization

sup |S|
sup W

Maximum Test Profile Value 95% Threshold P-value
Change Point
1.916
3.609
0.562
3.624
4.823
8.032
0.233
4.187

*Maximization was over a range of  between 0.25 and 4.75.

After the change-point was found (even though p-values were high), a Cox model was fit with the
indicator variable included to represent the change point. Caution was taken in interpreting the
model since the estimation ignored the fact that the candidate change point was determined by
the test procedure using the same data set. This research was conducted under the assumption
that there was only one change point parameter τ but it can be extended easily to incorporate
multiple change points in time.
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Figure 24: Profiles of Score Test Processes
The resulting Cox PH model with the change point  set at 4.186 which was indicated by the
normalized test statistic yielded the following model:

 ; ,  



 exp?3.71 - 4.87 p 4.186C - 0.70 Z  0.14 Z

The reference were patients with both HCV and HCC living within 180 miles with the change point
at   4.186. The hazard ratios were reported in table 19 below. Likelihood Ratio, Score and

Wald statistics all agreed that this model was statistically significant (p-value<0.0001) and the AIC
value was 1919.314.
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Table 19: Cox PH Model with 

 4.186

Analysis of Maximum Likelihood Estimates

Parameter

DF

Parameter

Standard

Estimate

Error

ChiSquare

Pvalue

Hazard
Ratio

HCV

n

1

-0.70363

0.16878

17.3802

<.0001

0.495

HCC

n

1

0.14235

0.19212

0.549

0.4587

1.153



0

1

3.70805

0.43698

72.0053

<.0001

40.774

0

1

-4.87466

0.44645

119.2172

<.0001

0.008

Next I fit the model with the change point   3.622 which was indicated by the non-normalized
score statistic and below are the resulting estimates.
Table 20: Cox PH model with 

 3.622

Analysis of Maximum Likelihood Estimates

Parameter

DF

Parameter

Standard

Estimate

Error

ChiSquare

Pvalue

Hazard
Ratio

HCV

n

1

-0.76966

0.16745

21.1278

<.0001

0.463

HCC

n

1

0.15028

0.19178

0.614

0.4333

1.162



0

1

2.99874

0.38993

59.1447

<.0001

20.06

0

1

-4.89206

0.46594

110.2361

<.0001

0.008

AIC was 1922.756 which was larger than 1919.314 from the model with   4.186 indicating

worse fit statistically. Likelihood Ratio, Score and Wald statistics were all in agreement that this
model was significant (p-value<0.0001).

It was known from the work of Liu et al. (2008) that accuracy of the approximation and power
increased with sample size and instability of the variance could be seen when there were few
deaths such as the case with this data (78.32% censored). The authors also established that the
maximum normalized value of the score statistic was less sensitive in the detection of a change
point than that based on the non-normalized score. The maximum normalized value for the test
score statistic was also more conservative under the null hypothesis (Liu et al., 2008). Even
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though the AIC score was lower for the Cox PH model with the change point established by the
normalized score (  4.186), I presented both in this analysis since the non-normalized score

(which showed   3.622) was more sensitive to change point detection.
3.8.2 Extension 1: Drop β

I dropped , to determine if distance Z did not have a throughout effect, but only an effect after a

certain time .

 ; ,  



 exp?  p C  #$

The p-values were 0.573 and 0.543 and the overall 5 per cent significance level thresholds were
3.387 and 7.592 for M and M*, respectively, based on 100,000 resampling samples. The
thresholds were presented by the horizontal lines in the plot. The potential change point locations
in terms of achieving the maximal score statistics were at 3.622 years post LT for both |&k #; |

(non-normalized) and k #;  (normalized) respectively.
Table 21: Change Point Detection Without

sup |S|
sup W

Maximum Test Profile Value 95% Threshold P-value Change Point
1.915
3.387
0.573
3.622
2.624
7.592
0.543
3.622

By dropping beta and increasing the number of resampling samples to 100,000 instead of 10,000,
the normalized and non-normalized test statistics agreed at 3.622. A Cox PH model was fit
illustrating that distance (dichotomized at 180) was significant (p-value < 0.0001) after 3.622
years post LT. I concluded that the hazard of death for patients living beyond 180 miles of the LT
center had 2.023 times the death rate before (and including) 3.622 years compared to those who
lived within 180, after adjusting for HCV and HCC. However this model had to be interpreted with
caution since there was evidence of a throughout distance effect as indicated in the previous
approach.
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Table 22: Cox PH Including a Change Point Without
Analysis of Maximum Likelihood Estimates
Parameter

DF Parameter Standard Chi-Square P-value Hazard
Estimate
Error
Ratio

HCC

n

1

0.2544

0.4709

0.2918

0.5891

1.290

HCV

n

1

0.7794

0.1781

19.1598

<.0001

2.180

0.9280

0.2340

15.7305

<.0001

2.530

0.7047

0.4172

0.8536

0.0912

2.023

Both
Z(t)

0

1

Likelihood Ratio, Score and Wald statistics all agreed that this model was significant (pvalue<0.0001). AIC was 1954.936. Since the AIC increased, and β was significant in table 19, I
concluded that β should remain in the model and there was evidence of a throughout effect of
distance on survival when distance was dichotomized at 180 miles.

Figure 25: MC Approach With β Dropped
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3.8.3 Extension 2: Reversed Inequality Sign
I changed 

p  to    which was a statistically equivalent model but had a more

was not retained in the model, this meant there was

natural interpretation in this dataset. Since

only a distance effect for times greater than  and when

was retained, this meant that there

was an additional effect due to distance after a certain point in time post-transplant, .

 ; ,  



 exp?    C  #$

In this model, I adjusted for HCV (1: yes; 0: no) and HCC (1: yes; 0: no) as X(t) before modeling
distance Z (1: within 180, 0: beyond 180) since these diseases are known to recur and therefore
reduce survival. The p-values were 0.080 and 0.315 and the overall 5 per cent significance level
thresholds were 4.855 and 7.491 for M and M*, based on 100,000 resampling samples. The
thresholds were presented by the horizontal lines in the plot in figure 25. The potential change
point locations in terms of achieving the maximal score statistics were at 0.286 years post LT for
|&k #; | and k #; .

Table 23: Change Point Detection with Inequality reversed

sup |S|
sup W

Maximum Test Profile Value
95% Threshold P-value
Change Point
4.430
4.855
0.080
0.286
3.718
7.491
0.315
0.286

The normalized and non-normalized score statistics showed agreement at a change point  of

0.286 years post-transplant possibly due to random variation in the Monte Carlo. The Cox PH
model was fit using this change point and the resulting model is shown in table 24 below. Both
and  were statistically significant indicating a distance effect throughout the 5 year period (p-

value=0.0002 for ) as well as an additional burden of distance beyond 180 miles (p-

value<0.0001 for ) on post-transplant survival.
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Table 24: Cox PH with the Inequality Reversed
Analysis of Maximum Likelihood Estimates
Parameter

DF

Parameter

Standard

Estimate

Error

ChiSquare

P-value

HR

HCC

1

0.245

0.471

0.271

0.602

1.278

HCV

1

0.782

0.178

19.304

<0.001

2.187

Both

1

0.942

0.234

16.138

<0.001

2.564

Z

1

0.882

0.419

4.436

0.035

2.416

3.8.4 Extension 3: Dichotomizing Distance at c
Distance was dichotomized using the model as opposed to a pre-specified value for c=180 miles,
replacing Z by I(Z>c), and extending the approach in Liu et al (2008) to estimate the change point
c in addition to . The hazard function used was:

 ; ,  

The likelihood function
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A two-step process was used. First estimates for η were obtained from a Cox PH model with no

change point , fit with distance pre-dichotomized at 180 miles which seemed to be a reasonable
estimate from the previous models. These estimates were nu*  0.789 (for HCV) and nuM  0.162
(for HCC). The values were used as initial values for obtaining estimates for all six parameters
simultaneously, which were , ", , , n* , and nM .
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The log-likelihood function was optimized using the Nelder-Mead, a variable metric algorithm, and
a simulated annealing algorithm. The algorithms were used to obtain estimates for

, ", , , n* , and nM simultaneously. Convergence was achieved using all three methods and the

results were presented in table 25 below.

Table 25: Resulting Estimates for Extension 3

Initial
Values
Τ
C
Θ
Β
γ1
γ2
Number of function calls
Gradient
Improvement in loglikelihood

3.66
180
0
0.989
0.789
0.162

Nelder-Mead

SANN

BFGS

3.622
179.767
1.144
0.909
0.764
0.084
523
NA
1.211

4.082
184.691
1.455
0.960
0.827
0.171
10000
NA
1.300

3.474
180.085
0.965
0.855
0.791
0.162
50
11
1.092

The change point in time ranged from 3.474 and 4.082, while the distance cutoff ranged from
179.767 and 184.691. Since these values did not deviate significantly from the initial values, I
used different carefully chosen (table 26) as well as random (table 27) starting values and was
able to confirm that these estimates maximized the log-likelihood. I found these constituted a
global maximum, not just a local one. Although it appeared that the change point in the hazard
function  could not be established with BFGS and SANN, the distance cutoff using SANN was

still close to 180 miles, confirming the distance cutoff, and BFGS was not far off either. This led
to reinforcing the conclusion that the choice of initial values is critical, and had to be made
carefully.
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Table 26: Extension 3 with Different Initial Values
(a)

Initial values

Nelder-Mead

BFGS

SANN

Τ
C
Θ
Β

3
100
2
1

4.057
139.591
1.142
0.214

NA
179.87
-0.157
0.987

NA
180.625
5.057
1.007

γ1

0.8

0.781

0.789

0.794

γ2

0.16

0.153

0.162

0.158

Initial values

Nelder-Mead

BFGS

SANN

Τ
C
Θ
Β

4
200
1
0

4.093
192
4.649
-1.89

3.997
200
1
0

0
183.217
0.41
1.018

γ1

0.8

0.876

0.8

0.771

γ2

0.16

0.16

0.16

0.168

(b)

In the scenario in table (a) where the initial values were below what we expect, BFGS and SANN
did not converge to anything for distance c. In the scenario in table (b) where the initial values
were above what we expected, SANN did not produce an estimate for the change point in time.

Next I used the uniform distribution to generate random initial values with the ranges indicated in
table 27 below. The log-likelihood was maximized and the resulting end values were displayed in
table 27 below. None of these three algorithms were able to determine a change point in the
hazard function when the initial values were generated randomly; they all converged to zero,
which was the boundary of the search range.

78

Table 27: Parameter Estimates for Extension 3 Using Random Initial Values

Τ
C
Θ
Β
γ1
γ2

Initial Values

Nelder-Mead

BFGS

SANN

U (observed
death times)
(0, 250)
(-2, 2)
(-2, 2)
(-2, 2)

0
55.833
-0.379
0.309

0
140.088
0.233
0.076

0
183.262
0.619
0.39

0.78

0.786

0.768

0.154

0.138

0.195

(-2, 2)

A grid search was performed over 20 values of  between 2 and 3.8 and 20 distance values

between 120 and 200. The grid was 20x20. The non-normalized score M, normalized score M*
and the two parameter score M2P were calculated to account for both the change point and
distance cutoff simultaneously, and the values of  2.758 and c=195.79 maximized this,
although this did not reach statistical significance (p-value=0.118) using the Monte Carlo
approach with 1000 repetitions.
Using a finer grid of 100x100 in the same range, the values for  2.455 and c=192.727

remained stable and the p-value was 0.146. The maximum value of the score was 7.469 which
were also in agreement with the coarse grid (2 parameter score maximized at 7.469). Table 28
summarizes these results. The M2p statistic consistently performed better than M and M*,

producing lower p-values. The grid size does not affect the power as seen in section 3.10 below
but both grid sizes were used to demonstrate in the table below. Further analysis of a 10x10,
20x20 and 30x30 can be seen in table 38.
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Table 28: Score Values for Extension 3

Grid

Type of Score

Coarse 2 Parameter
NonCoarse normalized
Coarse Normalized
Fine
Fine
Fine

2 Parameter
Nonnormalized
Normalized

Results
(τ, c)
(2.758,
195.790)

Max Value
θ
β
7.469

θ

β

0.118

3.087
2.411
(2.455,
192.727)

P-value

5.536
4.736

7.469

0.279
0.383

0.173
0.123

0.146

3.16
2.437

5.536
4.736

0.256
0.39

0.166
0.155

Below in figure 26 is an image plot of values for  and c. The fine grid (100x100) was used for

this plot. The 3D plot in figure 27 was more informative for this approach but both are displayed
here for completeness.

c

Figure 26: Image Plot of Extension 3
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Figure 27: 3D Plot of Extension 3

3.8.5 Extension 4: Increasing Distance Effect
Distance Z was replaced by max(Z-c,0), the positive part of the difference between distance and
the cutoff point (Z-c). This meant there was no distance effect for distances less than c, but
allowed the effect to increase for larger distances. The hazard function in this case was:

 ; ,  



 exp?    Cmax - ", 0  #$ 

Using the initial values:   3.66, c=180,   0,

parameter estimates in Table 29 were obtained.

 0.989, n*  0.789, and nM  0.162, the
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Table 29: Increasing Distance Effect

Nelder-Mead

SANN

BFGS

Τ
C
Θ
Β

4.079
201.209
0.008
0.844

1.567
180.9
0.003
1.6

3.649
179.435
0.006
0.989

γ1

0.079

0.824

0.79

γ2
Number of function calls
Gradient
Improvement in log-likelihood

0.016
149

0.122
10000

3.535

251.166

0.162
33
5
3.483

The distance cutoff was consistently in the region of 180 miles using the variable metric algorithm
(BFGS) and simulated annealing (SANN), while the Nelder-Mead approximation was higher at
200 miles. The SANN method yielded the best improvement in the log-likelihood out of all three
methods used for optimization. Using different initial values, the results are presented in table 30
below where only the Nelder-Mead approach yielded the first set of initial values.

Table 30: Increasing Distance Effect with Different Initial Values
(a)

Initial Values

Nelder-Mead

Τ
C
Θ
Β

4
200
1
0

NA
219.698
0.569
-0.336

γ1

0.8

0.78

γ2
Number of function calls

0.16

0.155
105

Increasing Distance Effect
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(b)

Initial Values

Nelder-Mead

BFGS

SANN

Τ
C
Θ
Β

3
200
1
0

4.109
201.14
0.008
0.386

NA
NA
NA
0

2.936
156.291
0.002
0.043

γ1

0.8

0.802

0.781

0.677

γ2
Number of function calls
Improvement in log-likelihood

0.16

0.014
435
12703.45

Initial Values

Nelder-Mead

BFGS

SANN

Τ
C
Θ
Β

4
150
1
0

4.2
194.798
-0.376
0.45

NA
NA
-0.057
0

2.844
93.307
0.002
0.208

γ1

0.8

0.78

0.78

0.905

γ2
Number of function calls
Improvement in log-likelihood

0.16

0.156
183
6307.6

0.156
0.076
13
10000
12699.92 12700.22

(c)

0.156
0.078
18
10000
6307.495 6309.171

Nelder-Mead was the most appropriate method for this data, but BFGS and SANN were used for
comparison purposes. Different initial values were used and Nelder-Mead approximation
produced the most consistent results which was expected.
A grid search was performed over 20 values of  between 2 and 3.8 and 20 distance values

between 120 and 200. The two parameter score was calculated to account for both the change
point and distance cutoff simultaneously, and the values of  4.237 and c=134.211 maximized

this, although this did not achieve statistical significance (p-value=0.118) using the Monte Carlo
approach with 1000 repetitions.
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Using a finer grid of 100x100 the values in the same range for  3.727 and c=192.727 and the

p-value was 0.161. The maximum value of the two parameter score was 5.082.

Figure 28: MC Approach of Two Parameter Score for Extension 4

(a) Coarse 20x20 grid

(b) Finer 100x100 grid
Figure 29: 3D Image Plots of Increasing Distance Effect
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Table 31: Results for Score Function in Extension 4

Grid
Type
Coarse 2 Parameter
NonCoarse normalized
Coarse Normalized
Fine
Fine
Fine

2 Parameter
Nonnormalized
Normalized

Results
(τ, c)
(4.237, 134.11)

Max Value
θ
β
7.344
228.677
4.237

(3.727,
192.727)

94.566
0.906

5.082
233.101
1.567

P-value
θ
β
0.118
0.287 0.792
0.173 0.569
0.161

94.832
0.719

0.3 0.789
0.368
0.6

3.9 Simulation Results
This section presents simulation results for Extensions 3 and 4 described in Section 2.4. Two
types of simulations were run, one using data generated from standard distributions and one with
a situation which closely resembled the data set of LT patients. The purpose of the first
simulation was to demonstrate that the methodology worked while the second simulation studies
its performance in a situation resembling the LT data. The simulations used covariates Z and (X1,
X2) with distributions described below.

3.9.1 Using Standard Distributions
The covariate X1 was generated from a uniform distribution with range (0,1), and X2 was
generated from an exponential distribution with mean=1. The sample size was n=600, with 1000
runs of simulations, and the thresholds for 1000 simulated datasets and thresholds based on
1000 Monte Carlo resampling samples. Z was generated from a uniform distribution on (0.100)

for extension 3 and (0,10) for extension 4.  was chosen to be 0.25 and the distance cutoff was

chosen to be 50. The grid was 20x20 and  ranged from 0.15 to 0.30 while c ranged from 20 to
60. The simulation results are summarized below.

For all 3 types of statistics M, M* and M2P, the Monte Carlo resampling-based thresholds
matched the empirical values reasonably well (Table 32). More specifically, the empirical
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threshold corresponding to a nominal level α was estimated by the 100(1-α) quantile of the
sample test statistics from 1000 data sets simulated under the null hypothesis. The average
Monte Carlo resampling-based threshold was defined as the mean of 1000 thresholds found by
the Monte Carlo resampling approach. We considered α levels of 0.1, 0.05, and 0.01 to examine
the tail approximation by the proposed Monte Carlo approach. The proximity between the
empirical threshold and the Monte Carlo resampling-based threshold indicated that the proposed
approach well approximated the distribution of the maximal score test statistics.

Table 32: Empirical and Resampling-based Thresholds at the Nominal Level α for Standard
Simulations
Sample
Extension
3

(θ, β ,γ1,
γ2)
(0, 0, 0.78,
0.16)

Empirical

Size
sup |S|

600

sup W

α=0.10

α=0.05

α=0.01

θ

19.2718

20.9852

26.5965

β

18.8528

21.2806

27.5332

θ

6.3836

7.748

11.3765

β

5.3341

6.829

10.6373

9.8826

11.4541

16.395

θ

19.4348

21.6797

26.0303

β

19.4131

21.638

25.6503

θ

6.6696

8.045

11.3061

β

5.6271

7.1691

10.8428

10.4484

12.2452

16.5111

M2P
4

(0, 0, 0.78,
0.16)

sup |S|

sup W

M2P

600

Resampling
α=0.10
19.0641
(0.6240)
18.9047
(0.6065)
6.1861
(0.2480)
5.3102
(0.2175)
9.5649
(0.3475)
19.0203
(0.6707)
18.8775
(0.6323)
6.1681
(0.2735)
5.3065
(0.2308)
9.5642
(0.3590)

α=0.05
21.3356
(0.7171)
21.3670
(0.7080)
7.6978
(0.3313)
6.7268
(0.2994)
11.2865
(0.4267)
21.2987
(0.7822)
21.3055
(0.7428)
7.6732
(0.3645)
6.7115
(0.3095)
11.2823
(0.4338)

α=0.01
25.7821
(1.0653)
26.0719
(1.0500)
11.0759
(0.6677)
9.9088
(0.6346)
15.0340
(0.7664)
25.7586
(1.0815)
26.0737
(1.1097)
11.0503
(0.6996)
9.9141
(0.6436)
15.0219
(0.7791)

In the 3 situations studied under extension 3 in table 33 below, the median estimated change
point  from 1000 replicated values was 0.2430, 0.2194, and 0.2285 in scenario 1, 2 and 3

respectively, ranging from 0.2194 to 0.2430. The median estimated change point from 1000
values, for the 3 scenarios were 0.2566, 0.2132, and 0.2289. Similarly the mean estimated
distance cutoff c was 58.46, 47.39, and 50.34 in scenarios 1, 2 and 3 with distance cutoff values
for 1000 replications ranging from 47.39 to 58.46. The median estimated distance cutoff was 60,
49.47, and 49.47. The null was excluded in these estimates given above.
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Likewise in table 33, 4 scenarios were studied for extension 4. The mean estimated change
points from 1000 values were 0.2197, 0.2195, 0.2155, and 0.2571 for scenarios 4, 5, 6 and 7
respectively. This ranges from 0.2155 to 0.2571 which captures the true value of 0.25. The
median estimated change points from 1000 values for the 4 scenarios were 0.2132, 0.2132,
0.2053, and 0.2911. The mean distance of 1000 values in scenarios 4 through 7, were 38.96,
46.61, 46.72, and 55.87 with the mean increasing as the values of

and  increased. The range

was 38.96 to 55.87 which captured the true value of 50 miles. The median estimated cutoffs from
1000 values were 38.95, 51.58, 51.58, and 55.79.

Under the null hypothesis of no change points, the estimators of the change points were spread
over the searched interval. When the change points actually existed under the alternatives, the
time and distance points yielding the maximal score statistics successfully captured the true
change-points of 0.25 years post-transplant and 50 miles as indicated by the median values of
their estimators.

Table 33: Standard Simulation Results
Recovered Value from Simulations
Extension

(β, θ, γ1, γ2)

Parameter

1

(0.02, 0.08,0.78,
0.16)

τ

0.25

0.243

0.2566

0.15

0.3

c

50

58.46

60

41.05

60

2

(0.3, 0.3, 0.78,
0.16)

τ

0.25

0.2194

0.2132

0.15

0.3

c

50

47.39

49.47

20

60

3

3

(0.6, 0.6, 0.78,
0.16)

τ

0.25

0.2285

0.2289

0.15

0.3

4

4

(0, 0.002, 1, 0.5)

3

3

4

Scenario

True
value

5

(0.008, 0, 1, 0.5)

4

6

(0.008, 0.002, 1,
0.5)

4

7

(0.15, 0.1,1,0.5)

Mean

Median

Minimum

Maximum

c

50

50.34

49.47

20

60

τ

0.25

0.2197

0.2132

0.15

0.3

c

50

38.96

38.95

20

60

τ

0.25

0.2195

0.2132

0.15

0.3

c

50

46.61

51.58

20

60

τ

0.25

0.2155

0.2053

0.15

0.3

c

50

46.72

51.58

20

60

τ

0.25

0.2571

0.2921

0.15

0.3

c

50

55.87

55.79

49.47

60
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Table 34: Type I Errors and Powers Using Resampling-based Thresholds for Standard
Simulations

Sample
Extension

(θ, β ,γ1, γ2)

3

(0, 0, 0.78,
0.16)

3

(0.3, 0.3,
0.78, 0.16)

3

(0.3, 0, 0.78,
0.16)

3

(0.4, 0.5,
0.78, 0.16)

3

(0.6, 0.8,
0.78, 0.16)

4

(0, 0, 0.78,
0.16)

4

(0.008, 0.002,
1, 0.5)

4

(0.008, 0, 1,
0.5)

4

(0, 0.002, 1,
0.5)

Size
θ

Resampling sup |S|
α=0.10

600

600

β
θ

600

β
θ

600

β
θ

600

β
θ

600

β
θ

600

β
θ

600

β
θ
β

600

α=0.01

α=0.10

α=0.05

α=0.01

0.106

0.042

0.014

0.105

0.055

0.01

0.1

0.051

0.012

0.105

0.055

0.01

0.907

0.84

0.653

0.897

0.819

0.632

0.919

0.862

0.682

0.906

0.846

0.669

0.205

0.136

0.039

0.196

0.122

0.033

0.194

0.122

0.029

0.19

0.119

0.032

0.782

0.626

0.267

0.712

0.508

0.174

0.725

0.573

0.232

0.725

0.545

0.182

0.817

0.67

0.296

0.702

0.504

0.145

0.843

0.703

0.344

0.81

0.643

0.276

0.108

0.061

0.009

0.117

0.06

0.011

0.117

0.054

0.009

0.114

0.06

0.011

0.566

0.438

0.222

0.551

0.423

0.204

0.613

0.488

0.264

0.594

0.472

0.259

0.107

0.059

0.01

0.111

0.054

0.01

0.12

0.056

0.01

0.114

0.06

0.009

0.555

0.435

0.214

0.539

0.418

0.206

0.606

0.493

0.244

0.588

0.476

0.233

β
θ

α=0.05

Resampling sup 2
Parameter Score

Resampling sup W

α=0.10

α=0.05

α=0.01

0.113

0.052

0.014

0.823

0.752

0.536

0.196

0.124

0.04

0.553

0.381

0.165

0.664

0.425

0.187

0.141

0.074

0.013

0.482

0.346

0.159

0.137

0.073

0.024

0.466

0.341

0.164

3.9.2 Using Original Data Structure
The purpose of the second simulation was to use the distance, HCV and HCC status from the
original data set to generate the survival times using a Cox PH model. The MC model in
extensions three and four of this dissertation was used to see how well the parameter estimates
could be recovered from this hybrid simulation using the real covariate values.

The coefficient for HCV was preset to 0.78 and the coefficient for HCC was 0.16 taken from the
Cox model estimated under the null hypothesis of no change points. Beta and theta were set to
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0.6 and 0.8 respectively for extension three, and 0.08 and 0.02 for extension four. The change

point in time  was set to 0.5 and the distance cutoff was 180. 1000 simulations with 1000 Monte

Carlo repetitions were run on a 20x20 grid of time between 0.25 and 0.75 and distance of 150 to
200.

For extension three, the two parameter score function (M2P) was maximized and was statistically
significant. In the 4 scenarios in table 35, the mean estimated change point , calculated from
1000 estimated values, were recovered at 0.5448, 0.5479, 0.5291, 0.534. These ranged from

0.5291 to 0.5479, depending on the values of the parameters β and θ used, which captured the
true value of 0.5. The median estimated change point for the 4 scenarios were 0.5658 and
0.5395 with 2 repetitions of each. The mean distance cutoff c from 1000 estimated values was
recovered at 177.2, 176.4, 180.2, and 177.5, which range between 176.4 and 180.2 which are
relatively close to the true values of 180. The median estimated change points from 1000 values
were 178.99 (three times) and 186.8.
Similarly for extension 4 in table 35 in scenarios 5 through 8, the mean estimated change point ,
calculated from 1000 estimated values, were recovered at 0.5097, 0.4981, 0.4942, and 0.4774,
ranging from 0.4774 to 0.5097 which captures the true value of 0.5. The median estimated
change points from 1000 values were 0.4868 and 0.4605. The mean value for the distance cutoff
c, estimated from 1000 replicated values for scenarios 5 through 8 were 165.1, 152.5 and 161.2
in scenarios 5,6 and 8 where the true value was 180. The median estimated distance cutoff from
1000 values which were generated were 162.9, 163.2 and 159.2. In scenario 7 a true value of
100 miles was used which allowed for more patients with distances above this value and it is
noted that the mean recovered value was 94.11 and the median was 92.11 which was closer to

the true value of 100 miles. Values for n* and nM were intentionally varied between 0.78 and 0.16

for one option, and 1 and 0.5 for the second option as seen in table 35 below.
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Table 35: Simulations Resembling LT Data
Recovered Value from Simulations
Extension

Scenario
3

1

Parameter

(0.5, 0.7, 0.78, 0.16)

τ

0.5

0.5448

c

180

τ

0.5

c

180

176.4

178.9

150

200

τ

0.5

0.5291

0.5395

0.25

0.75

c

180

180.2

186.8

150

200

τ

0.5

0.534

0.5395

0.25

0.75

c

180

177.5

178.9

150

200

τ

0.5

0.5097

0.4868

0.25

0.75

c

180

165.1

162.9

150

185

τ

0.5

0.4981

0.4868

0.25

0.75

c

180

152.5

163.2

100

200

τ

0.5

0.4942

0.4868

0.25

0.75

c

100

94.11

92.11

50

150

τ

0.5

0.4774

0.4605

0.25

0.75

c

180

161.2

159.2

150

185

3

2

(0, 0.8, 0.78, 0.16)

3

3

(0.6, 0, 0.78, 0.16)

3

4

(0.6, 0.8, 0.78, 0.16)

4

5

(0, 0.02, 1, 0.5)

4

6

(0.008, 0.002,0.78,0.16)

4

7

(0.001, 0.004,1,0.5)

4

8

True
value

(β, θ, γ1, γ2)

(0.08, 0.02,0.78,0.16)

Mean

Median

Minimum

Maximum

0.5658

0.25

0.75

177.2

178.9

150

200

0.5479

0.5658

0.25

0.75

The LT data-based simulation produced rather poor results compared to the standard simulation
with respect to distance in the fourth extension, probably due to the small number of patients
living at longer distances.

For all 3 types of statistics M, M* and M2p, the Monte Carlo resampling-based thresholds did not
match the empirical values well (Table 36). M produced the best agreement, M* was rather poor
and M2P did not perform well perhaps because of the small number of patients living at longer
distances. I considered α level of 0.1, 0.05, and 0.01 to examine the tail approximation by the
proposed Monte Carlo approach. The reasonable proximity between the empirical threshold and
the Monte Carlo resampling-based threshold indicated that the proposed approach well
approximated the distribution of the maximal score test statistics.

90

Table 36: Empirical and Resampling-based Thresholds at the Nominal Level α for Simulations
Resembling the LT Data
Sample
Approach
3

(θ, β ,γ1, γ2)
(0, 0, 0.78,
0.16)

Empirical

Size
sup |S|

821

sup W

α=0.10

(0, 0, 0.78,
0.16)

sup |S|

sup W

821

α=0.01

α=0.10

α=0.05

α=0.01

θ

5.319

5.9912

7.4405

4.9572
(0.6752)

5.6746
(0.7627)

7.0773
(0.9430)

β

5.5346

6.4579

8.2997

5.3186
(0.5623)

6.1400
(0.6482)

7.7493
(0.8381)

θ

8.2162

10.945

16.834

5.7283
(0.5024)

7.1647
(0.5579)

10.4095
(0.8227)

β

6.873

8.485

11.729

5.0819
(0.2782)

6.4699
(0.3354)

9.5737
(0.6331)

20.9984

22.933

25.404

8.3956
(0.5691)

10.0184
(0.6250)

13.5376
(0.8878)

θ

327.139

394.15

630.12

307.0252
(147.2931)

361.5709
(174.2347)

468.0873
(226.0252)

β

338.818

410.84

596.79

334.9368
(136.9262)

397.7352
(162.2611)

519.7167
(212.2840)

θ

5.5208

6.6549

8.8947

3.8259
(0.5114)

5.1094
(0.5965)

8.1263
(0.8526)

β

4.5681

5.332

8.3525

3.3507
(0.2589)

4.5755
(0.3322)

7.5003
(0.6697)

13.031

13.7843

14.8645

6.7186
(0.6905)

8.2969
(0.7559)

11.7940
(1.0121)

M2P

4

α=0.05

Resampling

M2P

Under the null hypothesis of no change points, the estimators of the change points were spread
over the searched interval. When the change points actually existed under the alternatives, the
time and distance points yielding the maximal score statistics successfully captured the true
change-points of 0.5 years post-transplant and 180 miles.

Although the methodology was successful in recovering the parameter values used to generate
this data, the simulations using standard distributions produced better results than those
resembling the LT data. I believe this is due to the small number of patients who lived beyond the
180 mile cutoff (n=19).
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Table 37: Type I Errors and Powers Using Resampling-based Thresholds for Simulations
Resembling the LT Data
Sampl
e
Ext

(θ, β ,γ1, γ2)

3

(0, 0, 0.78, 0.16)

3

(0, 0.6, 0.78,
0.16)

3

(0.7, 0.5, 0.78,
0.16)

Size
θ

821

β
θ

821

β
θ

821

β
3

(0.8, 0, 0.78,
0.16)

3

(0.8, 0.6, 0.78,
0.16)

θ

821

β
θ

821

β
4

(0, 0, 0.78, 0.16)

4

(0, 0.08, 0.78,
0.16)

θ

821

β
θ

821

β
4

(0.02, 0, 0.78,
0.16)

4

(0.4, 0.6, 0.78,
0.16)

θ

821

β
θ

821

β
4

(0.001,
0.004,1,0.5)

4

(0.08, 0.02,
0.78, 0.16)

θ

821

β
θ
β

821

Resampling sup |S|
α=0.1
α=0.0
α=0.0
0
5
1

Resampling sup W
α=0.1
α=0.0
α=0.0
0
5
1

0.146

0.068

0.02

0.256

0.146

0.05

0.116

0.057

0.017

0.201

0.114

0.022

0.214

0.113

0.019

0.168

0.065

0.011

0.255

0.141

0.026

0.224

0.109

0.015

0.690

0.49

0.145

0.531

0.330

0.068

0.683

0.515

0.184

0.638

0.439

0.125

0.356

0.202

0.029

0.241

0.098

0.007

0.311

0.154

0.027

0.251

0.116

0.013

0.817

0.67

0.296

0.702

0.504

0.145

0.843

0.703

0.344

0.81

0.643

0.276

0.175

0.105

0.029

0.21

0.105

0.017

0.156

0.093

0.022

0.202

0.085

0.018

0.326

0.18

0.018

0.215

0.092

0.008

1

0.993

0.143

1

0.98

0.074

0.53

0.142

0.002

0.125

0.029

0.002

0.53

0.149

0.002

0.473

0.093

0.001

0.5

0.340

0.090

0.373

0.198

0.029

0.507

0.352

0.111

0.466

0.287

0.071

0.433

0.274

0.063

0.357

0.198

0.033

0.408

0.263

0.072

0.388

0.229

0.047

0.42

0.249

0.039

0.311

0.15

0.007

1

0.995

0.224

1

0.992

0.122

Resampling M2P
α=0.10

α=0.05

α=0.01

0.609

0.497

0.351

0.4

0.248

0.149

0.583

0.359

0.201

0.585

0.434

0.326

0.664

0.425

0.187

0.419

0.305

0.141

0.747

0.415

0.046

0.344

0.264

0.126

0.508

0.331

0.201

0.325

0.191

0.090

0.838

0.526

0.075

In future studies with more patients living beyond the critical cutoff point, this will no longer be an
issue and the two types of simulations will produce comparable results.

3.10 Varying Grid Size
Next we explored the grid size to see if there was any impact on the power and we found that
there was none.
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Table 38: Grid Size

Sample
Grid size

Resampling sup W

α=0.10

α=0.05

α=0.01

α=0.10

α=0.05

α=0.01

0.9

0.85

0.647

0.888

0.838

0.621

0.919

0.868

0.705

0.912

0.857

0.685

0.906

0.835

0.655

0.890

0.822

0.643

0.923

0.870

0.699

0.916

0.853

0.688

0.913

0.855

0.667

0.9

0.838

0.655

β
0.931
0.883 0.685
τ  0.251, c  50, β  0.3, θ  0.3, γ*  1, γM  0.5

0.923

0.868

0.67

10

Size

Resampling sup |S|

θ

600

β
20

θ

600

β
30

θ

600

Resampling sup 2
Parameter Score
α=0.10

α=0.05

α=0.01

0.845

0.747

0.538

0.819

0.735

0.538

0.839

0.75

0.537

The grid size did not impact the power and this was demonstrated using various grid sizes
(10x10, 20x20 and 30x30) while keeping the parameters under the alternative constant as seen
in table 37.
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Chapter Four
Conclusion

4.1 Summary of Results
My study has demonstrated using extensive methodologies, that those patients who lived outside
of the 180 mile radius from TGH had a higher mortality rate during the first 5 years posttransplant. Using the AIC/ML approach applied to repeated Cox PH models, calculated for every
possible distance cutoff point (from 1 to 400 miles); it was established that 180 miles was where
the AIC was minimized. This corresponded to a driving distance of approximately three hours. It
was worth investigating further with other models to confirm the effect of distance on survival
post-transplant.

KM curves revealed higher mortality beyond 180 miles at five years post-transplant. Next, Cox
PH and AFT models adjusted for HCV and HCC, confirmed a distance effect on survival at 180
miles. LR at one year post-transplant confirmed that 180 miles was also a significant distance
cutoff. There are limitations with LR, which discards valuable information by ignoring the length
of patient survival and reducing outcomes to a dichotomous variable at a particular time point.
Models beyond one year post-transplant were calculated on a reduced dataset due to extensive
censoring. Therefore, greater emphasis was put on the findings of the Cox PH and AFT models.

The reason for adjusting for both HCV and HCC was that these diseases cause a higher mortality
due to disease recurrence. Patients with HCV and HCC have worse survival post-transplant
which was evident in this study. The effect of distance at 180 miles was more pronounced in
patients with HCV (HR of 3.72 for 434 HCV patients vs. 2.68 for total 821 patients) and even
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stronger in patients with HCC (HR of 5.24 for 134 HCC patients). 98 (12%) patients had both
HCV and HCC, as HCV often precedes HCC in liver disease progression.

In this dissertation, I extended current statistical methods for the use of Monte Carlo to establish a
p-value for the change point in the hazard function and incorporated both a change point in time
and a change point due to a continuous variable, in this case distance. In this dataset of LT
recipients, the new model was applied to simultaneously dichotomize distance and establish a
point in time where there was a change in the hazard function.

Using the approach proposed by Liu et al. (2008), the non-normalized score function pointed to a
change point at 3.622 years post LT but failed to reach statistical significance (p-value=0.566).
The normalized score pointed to a change point at 4.186 years post LT but failed to yield
statistical significance (p-value=0.235).

My first extension used distance dichotomized at 180 miles and allowed one to drop β, indicating
that there was no throughout distance effect. With this model, the distance effect was only
present prior to a specific point in time which was established at 3.622 years post-transplant, with
a hazard ratio of 0.011, indicating that the hazard of death was lower for those patients living
within 180 miles in the first 3.6 years post-transplant. Neither the non-normalized score function
nor the normalized score function reached statistical significance with p-values 0.573 and 0.543
respectively.

My second extension enabled reversal of the inequality sign to allow for an additional effect of
distance dichotomized at 180 miles, on the hazard beyond a certain time point which was more
intuitive for this data. This was found to be 3.663 years post-transplant but failed to reach
statistical significance for both the non-normalized and normalized score function with p-values
0.789 and 0.642 respectively.
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With the third extension I was able to allow the data to determine the best cutoff for distance while
simultaneously detecting the change point in the hazard function. This was done by maximizing
the log-likelihood over six parameters , ", , , n* , and nM using the Nelder-Mead, BFGS and

SANN optimization methods. The various methods were in close agreement over the distance
cutoff at 180 miles and a change point in the hazard between 3.5 and 4 years post-transplant
depending on the optimization method used. Using the Monte Carlo approach with a fine grid of
100x100, the change point was established at 2.455 years post LT and the distance cutoff was at
192.727 miles (p-value 0.146).

The fourth approach allowed for an incremental addition to the hazard beyond a mileage cutoff
point found at around 180 miles. This implied that for every additional mile beyond 180, there
was an incremental impact on survival. The change point in the hazard function was between 3.6
and 4 years post-transplant. Various different initial values were used in the optimization for
extensions three and four but the distance effect remained stable and close to 180 miles,
confirming what the previous models found. Using the Monte Carlo approach with a fine grid of
100x100, the change point was established at 3.727 years post LT and the distance cutoff was at
192.727 miles (p-value=0.161).

The models studied were consistent in determining that the distance cutoff in survival was 180
miles, although some failed to reach statistical significance. As explained in the results section, I
explored various other distance cutoffs within each method and none reached the significance
level of the 180 mile cutoff. Extensions three and four in the MC approach provided a novel
method to determine the distance cutoff.

The best model for this data was the third approach
 ; ,  



 exp?    C ! "  #$ 
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which dichotomized distance Z at a point c and then estimated the change points c and . This

model pointed to a distance effect beyond 192.727 miles with a change point in the hazard due to
this, after 2.455 years post-transplant.

Extensive simulations using both standard simulation techniques and a hybrid simulation
resembling the LT data, proved that these new approaches work for dichotomizing a continuous
variable and finding a point beyond which there was an incremental effect from this variable.
Various values of

and  were used and the median of the recovered values for  and c, were

very close to the true values.

4.2 This Study in Context
Studies in the past have been significantly smaller and conducted survival analysis using a small
sample size of 66 LT patients with very few of these at longer distances (Firozvi et al., 2008).
That study also calculated survival at one year post-transplant, a time period too short to evaluate
the multiple difficulties that the patients may encounter in their follow-up course. These difficulties
include, but are not limited to rejections, infections, HCV or HCC recurrence, medication
compliance, and other complications of LT.

My study was more comprehensive since I had 821 patients, over the span of 16 years, at longer
distance, and with a follow-up of up to 5 years after LT. I excluded patients who had relocated
temporarily to be closer to the LT center for purposes of receiving a transplant so this significant
bias present in other studies was eliminated. These patients had a transplant center or specialist
caring for them near their original residence so TGH was not solely responsible for their follow-up
care, and their inclusion would have biased the study. I decided to focus on patients within the
state of Florida, where driving distances can be as long as 7 hours for those patients driving from
the panhandle. Those with acute liver failure were also excluded, as they had a high early
mortality and a different set of circumstances regarding access to transplant centers and
compliance. This methodology was not described in other studies (Firozvi et al., 2008). Also
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excluded were those with early deaths during their LT hospitalization, as they were not impacted
by distance, travel time, or post-transplant care. Furthermore, adjustment was made for important
covariates, such as for the presence of HCV and HCC which are diseases most likely to recur. I
made a conscious effort to eliminate bias, which I believe has strengthened this study.

Using this unique and extensive methodology, my study was able to detect a distance effect on
post-transplant survival beyond 180 miles which other studies were previously unable to find.
The MC approach provided additional information that there was a change point in the hazard
with an additional distance effect after 3.6 years post-transplant, a factor that had not been
studied before in this patient population. The Nelder-Mead approximation, a variable metric
algorithm (BFGS), and a simulated annealing algorithm (SANN) were used to simultaneously

estimate , ", , , n* , and nM . This was necessary since the log-likelihood was discontinuous at 
and c, and therefore not differentiable.

4.3 Contribution
This is the first study to show that the patient’s distance from the transplant center can affect
survival after the LT. My study is more comprehensive, because it included a large patient pool
over the span of 16 years, and the use of multiple statistical models and approximation methods
to confirm the findings. I utilized AIC, Kaplan Meier, Cox PH, Accelerated Failure Time models,
Logistic Regression and a Monte Carlo approach to change point detection.

The Monte Carlo approach to change point detection and continuous variable dichotomization
developed here is applicable to dichotomizing any continuous variable in multiple therapeutic
areas. This is a new approach to change point detection that had not been in use before. My
fourth approach also allows for an incremental effect beyond a certain cutoff point which is a
novel approach.
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My study adds to the existing literature and clarifies the role of distance on post-transplant
survival for those undergoing LT, a topic somewhat controversial, tightly interwoven to concepts
of liver allocation, transplant centers and designations of centers of excellence, post-transplant
care, and overall utility of transplants in selected populations.

4.4 Findings
This dissertation is the first of its kind to study the effect of distance five years post LT, since
previous papers looked at shorter time periods. It is also the first study to consider a change
point in the hazard function due to distance and to demonstrate such a data driven approach to
dichotomizing distance using the MC approach.

The findings here indicated that travelling longer distances was detrimental to patient survival
which makes a strong argument against fewer but larger transplant centers. Studies in the past
conducted survival analysis using a small sample sizes (66 patients) with very few of these at
longer distances (Firozvi et al., 2008) and followed for a shorter period of time. This study was
more comprehensive in that there were a total of 821 patients over the span of 16 years, at longer
distance, and with a follow-up of five years after LT. As the MC approach indicated there is a
detrimental effect due to distance beyond 180 miles, and this effect is stronger after 3.6 years
post-transplant. Other studies would have missed this since they did not follow patients that long.
I recognize that this data would carry more weight if it had a more even distribution of distant
patients but the geography of Florida is such that most of the population is concentrated in the
larger cities. Given that Tampa Bay Area is considered a large metropolitan region with many
nearby suburban and rural areas, 180 miles does approximate to 3 hours of driving. For other LT
centers that are located in urban areas, this may not be the case.

Minimizing the AIC as previously described, lead to a distance cutoff of 180 miles. Using Cox PH
and AFT, after adjusting for HCV and HCC, I found that patients living beyond 180 miles from the
LT center had worse survival in a time period of five years post LT. LR at one year post LT also
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revealed that 180 miles was a significant distance cutoff. HCV and HCC impacted survival post
LT and were clearly noticeable in this study. Patients living beyond 180 miles had significantly
worse survival. This is crucial information because the medical community can monitor this
subgroup more aggressively to improve survival in the future. In the case of patients with HCV,
the effect of distance on survival post LT appeared to be worse.

There was clearly a prejudicious effect of distance on survival which was not previously confirmed
on post LT patients. When dichotomizing distance at 180 miles, those living further had a
significant disadvantage in survival (Log-Rank test statistic (p-value=0.0049), Wilcoxon (pvalue=0.0077) and the Likelihood Ratio Statistic (p-values=0.0154). Logistic Regression 1 year
post LT confirmed that 180 (p-value=0.0292) was significant. This is the first study to
demonstrate that the patient’s distance from a LT center can affect survival post LT.

The five methods studied (KM, Cox PH, AFT, LR, and MC approach) were consistent in
determining that the cutoff in survival was 180 miles, all of which were statistically significant. I
explored various other distance cutoffs within each method and none reached the significance
level of the 180 mile cutoff.

To limit biases, I excluded patients who had relocated temporarily to be closer to the LT center.
This would invalidate any study of the effect of distance since these patients get transferred back
to their original institutions. Patients with multiple organ transplants, acute liver failure, and death
on the same date as surgery were also excluded, as they had a different course of recovery.
Patients who died in the first 30 days (n=22) post LT could also be excluded since they did not
have a sufficiently long follow-up, and hence may not be affected much by traveling distance.
Therefore, I also reran the models excluding patients with early death, and the hazard ratio
increased from 2.68 to 3.15 because of the fact that all 22 of these patients lived within 180 miles
of the LT center. This implied that even though patients who lived closer had higher early
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mortality, including them did not change the finding that distant patients had higher mortality, and
excluding them actually further supports my hypothesis.

4.5 Implication of Findings in Public Health
This research is unique because it required substantial modification of standard methods in
survival analysis to incorporate dichotomization and the presence of change points in the hazard
function due to distance. I extended and improved upon the Monte Carlo method for change
point detection introduced by Liu et al (2008) to accommodate both a change point in the hazard
function due to distance at a point in time, and the dichotomization of distance (a continuous
variable) with a potential incremental effect. This recently developed method was not yet in
common use and described only in a journal article in Statistics in Medicine in 2008, yet I
extended it further to accommodate this dataset and the hypothesis that I was trying to prove. A
more complicated null hypothesis was employed than that of Liu et al (2008), to simultaneously
dichotomize distance at a point c and locate the time τ such that an enhanced distance effect is
observed for times greater than τ using a Monte Carlo (MC) approach. The MC approach for
change point detection that was developed in my dissertation is valuable in multiple scenarios
since it is applicable for dichotomizing other biomarkers to predict survival or time to
recurrence/graft failure in several other therapeutic areas apart from liver transplants.

By showing that patients at a longer distance exhibit poor survival, one can suggest that patients
should be transplanted at the nearest transplant center. Distance also plays a role in how organs
could be distributed. Indicating that results were worse at long distances, policy makers could
argue that allocation could be improved with multiple smaller LT centers as opposed to fewer
larger ones. It is also beneficial for health insurance companies to recognize that travelling a
longer distance hinders survival so patients should be encouraged to seek treatment at the
nearest LT center regardless of insurance-hospital contracts. From a patient perspective,
knowing that distance is a major obstacle to longer survival post-transplant could prompt them to
move closer to the center.
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To conclude, by using a larger pool of patients and more extensive methodology, I was able to
give more strength to this study compared to previous ones found in the literature. Methodology
that involved application of AIC to Cox PH and MC to establish the presence of change points in
the hazard had very recently been developed and has been extended further here. The MC
method that I developed was specially adapted to fit the needs of this dataset, specifically to
simultaneously estimate the dichotomization point for distance and the change point in the hazard
function, which makes this study unique. My new methodology is valuable in that it is the first of
its kind to simultaneously dichotomize a continuous variable, in this case distance, and establish
a change point in the hazard function attributed to this variable. Furthermore in the fourth
extension, the model allows for an incremental effect of distance beyond a certain cutoff point
which was previously not possible to model and obtain the statistical significance for this term.
Extensive simulation studies (in chapter 3) illustrate the value of this method. This methodology
has numerous applications in a countless therapeutic areas involving a vast array of possible
biomarkers.

4.6 Credibility
Bias was minimized by ensuring that both study groups had similar mean age, gender, and race
distribution. However, I found that mean MELD scores were significantly higher for patients who
lived closer, even though they had lower mortality post LT. High MELD scores (≥21) have been
an independent predictor of increased mortality (Heuman et al., 2004). This finding was of interest
because it implied that even though patients who lived closer had markers of increased mortality
prior to LT, they were not more likely to die after the LT. This further supports that distance effect
on mortality was very prominent in this study. However, the prevalence of HCC and HCV did not
differ significantly between the two groups. Again, even though distant patients had lower MELD
scores indicating a better survival prognosis, they still had increased mortality after LT. The
models were adjusted for HCV and HCC in order to eliminate their impact on post LT survival. I
demonstrated that these covariates did affect survival post LT. The effect of distance was more
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pronounced in patients with HCV (HR of 3.72 for 434 HCV patients vs. 2.5 for total 821 patients).
The distance effect was even stronger in patients with HCC (5.24 for 134 HCC patients).

Distance had a deleterious effect on patient survival post LT. This was shown using multiple
different statistical modeling techniques with the MC approach which I developed, being new.
Due to poor survival, allocation of resources may be needed for this distant population, especially
those with HCV and HCC. This study provides the data to support this need. Such resources
could include but not limited to, post LT HCV therapy, comorbidities, satellite clinics, mobile units
and in general availability of specialists in distant areas deserve further study. This research has
indicated that patients living beyond 180 miles from the LT center needed to be followed closely,
or timely follow-up at least attempted, so that their medical care is improved. Ideally, one would
want strategic partners caring for those patients far away that also have an interest in their
progress. If this care does not exist, then their health may suffer.

4.7 Limitations
This study was retrospective, single center and regional bias existed. A larger prospective study
would be beneficial in the future, where multiple additional covariates could be collected and
adjusted for and plans for this are currently underway. Power is the most important limitation in
this study. The small fraction of 19 patients living beyond 180 miles makes it impossible to find
statistically significant differences in some of the more complex models. Work status information
was incomplete in this retrospective data and therefore could not be studied. The geography of
Florida differs to other regions and the lack of mass transit in the state may have caused a
different distance effect as compared to other centers.

In this study patients who had relocated temporarily to be closer to the LT center were excluded,
since their postoperative travel for follow-up would be altered. The center of residential zip code
area was used to approximate the patient’s distance to TGH’s LT center. I recognize that zip
code areas are established by the U.S. Postal Services and could change over the years to

103

expedite mail delivery. This conceptual area tends to be larger in rural settings. Thus, for the 19
patients who lived over 180 miles from the TGH LT center, I have found that the center of their zip
code areas was not a large mileage discrepancy from their physical addresses as zip codes in
this area are relatively small. TGH’s LT center is located in downtown Tampa, FL, and since
Tampa is a part of a large metropolitan region, patients who lived within 180 miles should not
have a large zip code area. With this in mind I do not believe that using zip code instead of the
full address has compromised my estimate of distance and I believe this study to be accurate.

I did not examine potential difficulties that patients at long distances encountered, such as
compliance with appointments and medications. Difficulties that the patients may encounter in
their follow-up course include, but are not limited to rejections, infections, HCV or HCC
recurrence, medication compliance, and other complications following LT. Even though my study
attempted to minimize bias by adjusting for HCV and HCC, as well as making appropriate
exclusions, there could be other confounding variables that could affect survival post LT, such as
co-morbidities, BMI, perioperative parameters, insurance coverage, socioeconomic status, level
of education, or availability of nearby specialists. These factors have been debated regarding
disparities in allocation and distribution which affects access and mortality prior to LT, but it is
possible that these variables could also affect outcome post LT. In the literature review in chapter
one, I listed examples of these disparities and discussed them.

4.8 Using Results to Solve Problems
It was hypothesized that longer distance between the patient’s residence and the LT center
results in worse outcome post LT. Since this hypothesis was proven to hold true, LT centers
should make an effort to provide additional resources, such as finding temporary housing closer
to the LT center, scheduling follow-up visits and tests on the same day, offering blood tests in
local laboratory centers, fostering more frequent communication, recommending nearby
specialists, or even providing satellite clinics.
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Possible explanation for poor survival in the distant group, which were not studied here but will be
considered in future research, included the inconvenience of travelling a longer distance for
follow-up, the expense incurred by the patient when having to travel so far, transportation issues
since mass transit and railroad systems are practically non-existent in Florida, fewer follow-up
visits as it is suspected that those living further away were more likely to cancel, and the lack of
primary providers or specialists in the patient’s area.

It is evident that patients living more than 180 miles from the liver transplant center may need to
be followed closely. If post LT coordinators are aware of the distance effect they can follow those
patients more aggressively to ensure that they receive the necessary follow-up care to maintain a
healthy graft.

Health insurance companies should be aware that distance hinders survival, so patients can be
encouraged to seek treatment at the nearest LT center. This is not always done and due to
insurance contracts some patients are forced to drive long distances to receive LT and follow-up
treatment.

4.9 Future Research
There is a fundamental gap in understanding which socioeconomic factors affect long term
survival of LT. LT is the only therapy currently available for patients with end-stage liver disease.
Approximately 4,000 liver transplants are done yearly, but waiting lists are lengthening and a
shortage of organs has caused an increase in deaths among patients waiting for LT. After LT, the
survival rate appears to be lower for African-Americans than for Caucasians. Continued
existence of this gap poses an increasingly difficult problem in the LT community as allocation of
organs with limited supply becomes difficult to establish. The long term goal is to better
understand how socioeconomic factors affect access to LT and survival post LT. I plan to design
a Socioeconomic Predictive Model to predict survival post LT based on socioeconomic and
clinical factors with both a retrospective and a prospective component.
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I intend to further refine this study, by adding more patients to the dataset, hopefully having a
greater distribution of patients outside of 180 miles, adjusting for more confounding variables,
obtaining multicenter and multiregional data (discussions with UNC are underway), and by
acquiring the necessary software to enable using the entire physical residential address as
opposed to just the zip code.

By acquiring a larger sample size, I can randomly divide the data into two groups and carry out
the testing procedure and estimation separately on the two independent subsets. Given that I
had 821 patients with 19 living beyond 180 miles this was not possible here.

Another topic of interest to me is the association between the economic recession and the distant
patients’ outcomes, socioeconomic variables interacting with distance and other factors not
studied here such as compliance, difficulty maintaining appointments, difficulty maintaining HCV
treatment regimens, and lack of specialty providers.

Simulation studies would aid in establishing the properties of using the AIC criterion applied to
repeated Cox PH models to dichotomize a continuous variable. More covariates can be adjusted
for than what was available here.

The research group at TGH and I, are currently working together to study the effects of BMI on
complications measured by the Clavien-Dino classification scale post LT. The hypothesis is that
higher BMI will lead to more severe post LT complications, shorter graft survival and patient
survival. In addition we have designed a prospective study to assess the quality of life of HCC
patients undergoing LT.

4.10 Conclusion
My study has shown that patients who lived farther than 180 miles from a LT center had a higher
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mortality after LT than those who lived closer. Therefore, LT centers should consider this
information during initial evaluation of patients and provide additional resources to assist these
patients, especially those with HCV. This research has indicated that patients living more than
180 miles from the transplant center may need to be followed closely, so that their medical care is
improved. Ideally, one would want strategic partners caring for those patients far away that also
have an interest in their progress. If this care does not exist, outcomes will be poor.

It has also inspired a variety of difficult questions: Should patients be transplanted at their nearest
transplant center? Should distance play a role in how organs are distributed? Should insurance
companies send patients to distant transplant centers of excellent quality when the outcome, in
certain populations, is poor? Should aggressive centers transplant difficult patients from far
away? Should the trend be for fewer, larger centers? My study provides a partial answer to some
of these questions.
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Appendix A: Standard Simulation for Extension 3
remove(list=ls())
#ginv function was taken from MASS library of Venables and Ripley
ginv<function (X, tol = sqrt(.Machine$double.eps))
{
if (length(dim(X)) > 2L || !(is.numeric(X) || is.complex(X)))
stop("'X' must be a numeric or complex matrix")
if (!is.matrix(X))
X <- as.matrix(X)
Xsvd <- svd(X)
if (is.complex(X))
Xsvd$u <- Conj(Xsvd$u)
Positive <- Xsvd$d > max(tol * Xsvd$d[1L], 0)
if (all(Positive))
Xsvd$v %*% (1/Xsvd$d * t(Xsvd$u))
else if (!any(Positive))
array(0, dim(X)[2L:1L])
else Xsvd$v[, Positive, drop = FALSE] %*% ((1/Xsvd$d[Positive]) *
t(Xsvd$u[, Positive, drop = FALSE]))
}
mc.ext3<-function(TT,cen.ind,XX,dist,tau,cc,nrep,keep=FALSE) {
n<-nrow(XX)
np<-ncol(XX)
ntau<-length(tau)
ncc<-length(cc)
mod<-coxph(Surv(TT,cen.ind)~XX,method="breslow")
gamma<-mod$coeff
DD<-TT[cen.ind==1]
ndead<-length(DD)
d.ind<-(1:n)[cen.ind==1]
Dpos<-cbind(d.ind,1:ndead)
pp<-outer(TT,DD,">=")*exp(as.vector(XX%*%gamma))
pp<-scale(pp,center=FALSE,scale=colSums(pp))
S.obs<-array(0,dim=c(2,ntau,ncc))
score<-array(0,dim=c(n,2,ntau,ncc))
dimnames(score)<-list(NULL,c("theta","beta"),paste("tau",1:ntau,sep=""),
paste("cc",1:ncc,sep=""))
V<-array(0,dim=c(2,ntau,ncc))
Vinv<-array(0,dim=c(2,2,ntau,ncc))
da<-c(n,ndead,np+2)
X.all<-array(0,dim=da)
for(i in 1:np)X.all[,,i+2]<-XX[,i]
for(i in 1:ntau)for(j in 1:ncc){
X.all[,,1]<-outer(dist>cc[j],DD>=tau[i])
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X.all[,,2]<-(dist>cc[j])
Xbar0<-colSums(X.all*as.vector(pp))
X.all<-sweep(X.all,2:3,Xbar0)
dM<- -pp
dM[Dpos]<-dM[Dpos]+1
raw.score<-rowSums(aperm(X.all*as.vector(dM),c(1,3,2)),dims=2)
S.obs[,i,j]<-colSums(raw.score[,1:2])
B<-matrix(aperm(X.all*sqrt(as.vector(pp)),c(3,1,2)),da[3],da[1]*da[2])
info<-B%*%t(B)
dI<-nrow(info)
I12<-info[1:2,3:dI]
I22<-info[3:dI,3:dI]
score[,,i,j]<-S<-raw.score[,1:2]-t(I12%*%solve(I22,t(raw.score[,3:dI])))

tmp<-t(S)%*%S
V[,i,j]<-diag(tmp)
Vinv[,,i,j]<- if(is.matrix(B<-try(solve(tmp))))B else ginv(tmp)
}
score<-matrix(score,n,)
V<-matrix(V,2,)
Vinv<-array(Vinv,c(2,2,ntau*ncc))
Mstar<-M<-array(0,c(nrep,2))
M2p<-numeric(nrep)
if(keep)S.mc<-array(0,c(nrep,2,ntau,ncc))
S.obs<-matrix(S.obs,2,)
M.obs<-c(max(abs(S.obs[1,])),max(abs(S.obs[2,])))
W.obs<-S.obs^2/V
Mstar.obs<-c(max(W.obs[1,]),max(W.obs[2,]))
W2p.obs<-S.obs[1,]^2*Vinv[1,1,]+
2*S.obs[1,]*S.obs[2,]*Vinv[1,2,]+S.obs[2,]^2*Vinv[2,2,]
tauvec<-rep(tau,ncc)
ccvec<-rep(cc,rep(ntau,ncc))
i<-which.max(W2p.obs)
M2p.obs<-W2p.obs[i]
tau.max<-tauvec[i]
cc.max<-ccvec[i]

for(i in 1:nrep){
S<-matrix(rnorm(n)%*%score,2,)
M[i,]<-c(max(abs(S[1,])),max(abs(S[2,])))
W<-S^2/V
Mstar[i,]<-c(max(W[1,]),max(W[2,]))
M2p[i]<-max(S[1,]^2*Vinv[1,1,]+2*S[1,]*S[2,]*Vinv[1,2,]+S[2,]^2*Vinv[2,2,])
if(keep)S.mc[i,,,]<-as.vector(S)
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}

ans<-list(S.obs=array(S.obs,dim=c(2,ntau,ncc)),
W.obs=array(W.obs,dim=c(2,ntau,ncc)),
W2p.obs=array(W2p.obs,dim=c(ntau,ncc)),
tau.max=tau.max,cc.max=cc.max,
M.obs=M.obs,Mstar.obs=Mstar.obs,M2p.obs=M2p.obs,
p.M=pval(M.obs,M),p.Mstar=pval(Mstar.obs,Mstar),
p.M2p=pval(M2p.obs,M2p),
M.mc=M,Mstar.mc=Mstar,M2p.mc=M2p)
if(keep)ans<-c(ans,list(S.obs=array(S.obs,dim=c(2,ntau,ncc)),S.mc=S.mc))
ans
}
pval<-function(x,xdist){
rowMeans(t(xdist)>=x)
}
rchpt<-function(r1,r2,t){
w<-rexp(length(r1))
ifelse(w<r1*t,w/r1,t+(w-r1*t)/r2)
}
#########################################################################
############ Simulation #################################################
#########################################################################
library("survival")
n<-600
nrep<-1000
nsim<-1000
g1<-0.78
g2<-0.16
beta<-0.5
theta<-0.4
tau0<-.25
cc0<-50
ngrid=20
tau<-seq(.15,.3,length=ngrid)
cc<-seq(20,60,length=ngrid)

int.tau0<-c(.15,.35)
int.cc0<-c(40,60)
inside<-function(x,int){(int[1]<=x)&(x<=int[2])}
M<-Mstar<-p.M<-p.Mstar<-matrix(0,nsim,2)
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tau.max<-cc.max<-M2p<-p.M2p<-numeric(nsim)
alpha<-c(.10,.05,.01)
nam.alpha<-as.character(alpha)
nam.param<-c("theta","beta")

tau.max<-cc.max<-M2p<-p.M2p<-numeric(nsim)
M<-matrix(0,nsim,2)
colnames(M)<-nam.param
Mstar<-p.M<-p.Mstar<-M
q.M.mc<-array(0,dim=c(nsim,2,length(alpha)))
dimnames(q.M.mc)<-list(NULL,nam.param,nam.alpha)
q.Mstar.mc<-q.M.mc
q.M2p.mc<-matrix(0,nsim,length(alpha))
colnames(q.M2p.mc)<-nam.alpha

num.dead<-num.dead.box<-numeric(nsim)
for(i in 1:nsim){
cat(i,"\n")
x1<-runif(n)
x2<-rexp(n)
dist<-100*runif(n)
z<-(dist>cc0)+0
lambda1<-exp(r1<-g1*x1+g2*x2+beta*z)
lambda2<-exp(r1+theta*z)
ss<-10*rchpt(lambda1,lambda2,tau0)
uu<-4*rexp(n)
tt<-pmin(ss,uu)
delta<-(ss<=uu)+0
xx<-cbind(x1,x2)
ans<-mc.ext3(tt,delta,xx,dist,tau,cc,nrep)
M[i,]<-ans$M.obs
Mstar[i,]<-ans$Mstar.obs
p.M[i,]<-ans$p.M
p.Mstar[i,]<-ans$p.Mstar
tau.max[i]<-ans$tau.max
cc.max[i]<-ans$cc.max
M2p[i]<-ans$M2p.obs
p.M2p[i]<-ans$p.M2p
q.M.mc[i,,]<-t(apply(ans$M.mc,2,quantile,probs=1-alpha))
q.Mstar.mc[i,,]<-t(apply(ans$Mstar.mc,2,quantile,probs=1-alpha))
q.M2p.mc[i,]<-quantile(ans$M2p.mc,probs=1-alpha)
}

Mall<-cbind(M,Mstar,p.M,p.Mstar,tau.max,cc.max,M2p,p.M2p)
print(summary(Mall))
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print(apply(Mall,2,quantile,probs=seq(0,1,by=.1)))
q.M<-t(apply(M,2,quantile,probs=1-alpha))
q.Mstar<-t(apply(Mstar,2,quantile,probs=1-alpha))
q.M2p<-quantile(M2p,probs=1-alpha)
dimnames(q.M)<-dimnames(q.Mstar)<-list(nam.param,nam.alpha)
names(q.M2p)<-nam.alpha
pow<-function(p,a){colMeans(outer(p,a,"<"))}
power.M<-t(apply(p.M,2,pow,alpha))
power.Mstar<-t(apply(p.Mstar,2,pow,alpha))
dimnames(power.M)<-dimnames(power.Mstar)<-list(nam.param,nam.alpha)
power.M2p<-pow(p.M2p,alpha)
names(power.M2p)<-nam.alpha
mean.q.M.mc<-apply(q.M.mc,c(2,3),mean)
sd.q.M.mc<-apply(q.M.mc,c(2,3),sd)
mean.q.Mstar.mc<-apply(q.Mstar.mc,c(2,3),mean)
sd.q.Mstar.mc<-apply(q.Mstar.mc,c(2,3),sd)
mean.q.M2p.mc<-apply(q.M2p.mc,2,mean)
sd.q.M2p.mc<-apply(q.M2p.mc,2,sd)

OF<-mean(num.dead)/n
LF<-mean(num.dead.box)/n

q.M
q.Mstar
q.M2p

mean.q.M.mc
sd.q.M.mc
mean.q.Mstar.mc
sd.q.Mstar.mc
mean.q.M2p.mc
sd.q.M2p.mc

power.M
power.Mstar
power.M2p

OF
LF
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Appendix B: Standard Simulation for Extension 4
remove(list=ls())
#ginv function taken from MASS library of Venables and Ripley
ginv<function (X, tol = sqrt(.Machine$double.eps))
{
if (length(dim(X)) > 2L || !(is.numeric(X) || is.complex(X)))
stop("'X' must be a numeric or complex matrix")
if (!is.matrix(X))
X <- as.matrix(X)
Xsvd <- svd(X)
if (is.complex(X))
Xsvd$u <- Conj(Xsvd$u)
Positive <- Xsvd$d > max(tol * Xsvd$d[1L], 0)
if (all(Positive))
Xsvd$v %*% (1/Xsvd$d * t(Xsvd$u))
else if (!any(Positive))
array(0, dim(X)[2L:1L])
else Xsvd$v[, Positive, drop = FALSE] %*% ((1/Xsvd$d[Positive]) *
t(Xsvd$u[, Positive, drop = FALSE]))
}
mc.ext4<-function(TT,cen.ind,XX,dist,tau,cc,nrep,keep=FALSE) {

n<-nrow(XX)
np<-ncol(XX)
ntau<-length(tau)
ncc<-length(cc)
mod<-coxph(Surv(TT,cen.ind)~XX,method="breslow")
gamma<-mod$coeff
DD<-TT[cen.ind==1]
ndead<-length(DD)
d.ind<-(1:n)[cen.ind==1]
Dpos<-cbind(d.ind,1:ndead)
pp<-outer(TT,DD,">=")*exp(as.vector(XX%*%gamma))
pp<-scale(pp,center=FALSE,scale=colSums(pp))
S.obs<-array(0,dim=c(2,ntau,ncc))
score<-array(0,dim=c(n,2,ntau,ncc))
dimnames(score)<-list(NULL,c("theta","beta"),paste("tau",1:ntau,sep=""),
paste("cc",1:ncc,sep=""))
V<-array(0,dim=c(2,ntau,ncc))
Vinv<-array(0,dim=c(2,2,ntau,ncc))
da<-c(n,ndead,np+2)
X.all<-array(0,dim=da)
for(i in 1:np)X.all[,,i+2]<-XX[,i]
for(i in 1:ntau)for(j in 1:ncc){
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dmc<-pmax(dist-cc[j],0)
X.all[,,1]<-outer(dmc,DD>=tau[i])
X.all[,,2]<-dmc
Xbar0<-colSums(X.all*as.vector(pp))
X.all<-sweep(X.all,2:3,Xbar0)
dM<- -pp
dM[Dpos]<-dM[Dpos]+1
raw.score<-rowSums(aperm(X.all*as.vector(dM),c(1,3,2)),dims=2)
S.obs[,i,j]<-colSums(raw.score[,1:2])
B<-matrix(aperm(X.all*sqrt(as.vector(pp)),c(3,1,2)),da[3],da[1]*da[2])
info<-B%*%t(B)
dI<-nrow(info)
I12<-info[1:2,3:dI]
I22<-info[3:dI,3:dI]
score[,,i,j]<-S<-raw.score[,1:2]-t(I12%*%solve(I22,t(raw.score[,3:dI])))

tmp<-t(S)%*%S
V[,i,j]<-diag(tmp)
Vinv[,,i,j]<- if(is.matrix(B<-try(solve(tmp))))B else ginv(tmp)
}
score<-matrix(score,n,)
V<-matrix(V,2,)
Vinv<-array(Vinv,c(2,2,ntau*ncc))
Mstar<-M<-array(0,c(nrep,2))
M2p<-numeric(nrep)
if(keep)S.mc<-array(0,c(nrep,2,ntau,ncc))
S.obs<-matrix(S.obs,2,)
M.obs<-c(max(abs(S.obs[1,])),max(abs(S.obs[2,])))
W.obs<-S.obs^2/V
Mstar.obs<-c(max(W.obs[1,]),max(W.obs[2,]))
W2p.obs<-S.obs[1,]^2*Vinv[1,1,]+
2*S.obs[1,]*S.obs[2,]*Vinv[1,2,]+S.obs[2,]^2*Vinv[2,2,]
tauvec<-rep(tau,ncc)
ccvec<-rep(cc,rep(ntau,ncc))
i<-which.max(W2p.obs)
M2p.obs<-W2p.obs[i]
tau.max<-tauvec[i]
cc.max<-ccvec[i]
for(i in 1:nrep){
S<-matrix(rnorm(n)%*%score,2,)
M[i,]<-c(max(abs(S[1,])),max(abs(S[2,])))
W<-S^2/V
Mstar[i,]<-c(max(W[1,]),max(W[2,]))
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M2p[i]<-max(S[1,]^2*Vinv[1,1,]+2*S[1,]*S[2,]*Vinv[1,2,]+S[2,]^2*Vinv[2,2,])
if(keep)S.mc[i,,,]<-as.vector(S)
}
ans<-list(S.obs=array(S.obs,dim=c(2,ntau,ncc)),
W.obs=array(W.obs,dim=c(2,ntau,ncc)),
W2p.obs=array(W2p.obs,dim=c(ntau,ncc)),
tau.max=tau.max,cc.max=cc.max,
M.obs=M.obs,Mstar.obs=Mstar.obs,M2p.obs=M2p.obs,
p.M=pval(M.obs,M),p.Mstar=pval(Mstar.obs,Mstar),
p.M2p=pval(M2p.obs,M2p),
M.mc=M,Mstar.mc=Mstar,M2p.mc=M2p)
if(keep)ans<-c(ans,list(S.obs=array(S.obs,dim=c(2,ntau,ncc)),S.mc=S.mc))
ans
}
pval<-function(x,xdist){
rowMeans(t(xdist)>=x)
}
rchpt<-function(r1,r2,t){
w<-rexp(length(r1))
ifelse(w<r1*t,w/r1,t+(w-r1*t)/r2)
}
#########################################################################
############ Simulation #################################################
#########################################################################
library("survival")
n<-600
nrep<-1000
nsim<-1000
g1<-1
g2<-0.5
beta<-0.008
theta<-0.002
tau0<-.25
cc0<-50
ngrid=20
tau<-seq(.15,.3,length=ngrid)
cc<-seq(20,60,length=ngrid)

int.tau0<-c(.15,.35)
int.cc0<-c(40,60)
inside<-function(x,int){(int[1]<=x)&(x<=int[2])}
M<-Mstar<-p.M<-p.Mstar<-matrix(0,nsim,2)
tau.max<-cc.max<-M2p<-p.M2p<-numeric(nsim)
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baseline<-list(u=c(.15,1.75,3.3),r=c(.15,.048,.018,.038))
L.rpwexp<-setup.rcox.with.chpt(lambda1,lambda2,tau0,baseline)
alpha<-c(.10,.05,.01)

nam.alpha<-as.character(alpha)
nam.param<-c("theta","beta")
tau.max<-cc.max<-M2p<-p.M2p<-numeric(nsim)
M<-matrix(0,nsim,2)
colnames(M)<-nam.param
Mstar<-p.M<-p.Mstar<-M
q.M.mc<-array(0,dim=c(nsim,2,length(alpha)))
dimnames(q.M.mc)<-list(NULL,nam.param,nam.alpha)
q.Mstar.mc<-q.M.mc
q.M2p.mc<-matrix(0,nsim,length(alpha))
colnames(q.M2p.mc)<-nam.alpha

num.dead<-num.dead.box<-numeric(nsim)
for(i in 1:nsim){
cat(i,"\n")
x1<-runif(n)
x2<-rexp(n)
dist<-100*runif(n)
z<-pmax((dist-cc0)+0,0)
lambda1<-exp(r1<-g1*x1+g2*x2+beta*z)
lambda2<-exp(r1+theta*z)
ss<-10*rchpt(lambda1,lambda2,tau0)
uu<-4*rexp(n)
tt<-pmin(ss,uu)
delta<-(ss<=uu)+0
xx<-cbind(x1,x2)
ans<-mc.ext4(tt,delta,xx,dist,tau,cc,nrep)
M[i,]<-ans$M.obs
Mstar[i,]<-ans$Mstar.obs
p.M[i,]<-ans$p.M
p.Mstar[i,]<-ans$p.Mstar
tau.max[i]<-ans$tau.max
cc.max[i]<-ans$cc.max
M2p[i]<-ans$M2p.obs
p.M2p[i]<-ans$p.M2p
q.M.mc[i,,]<-t(apply(ans$M.mc,2,quantile,probs=1-alpha))
q.Mstar.mc[i,,]<-t(apply(ans$Mstar.mc,2,quantile,probs=1-alpha))
q.M2p.mc[i,]<-quantile(ans$M2p.mc,probs=1-alpha)
}
Mall<-cbind(M,Mstar,p.M,p.Mstar,tau.max,cc.max,M2p,p.M2p)
print(summary(Mall))
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print(apply(Mall,2,quantile,probs=seq(0,1,by=.1)))
q.M<-t(apply(M,2,quantile,probs=1-alpha))
q.Mstar<-t(apply(Mstar,2,quantile,probs=1-alpha))
q.M2p<-quantile(M2p,probs=1-alpha)
dimnames(q.M)<-dimnames(q.Mstar)<-list(nam.param,nam.alpha)
names(q.M2p)<-nam.alpha
pow<-function(p,a){colMeans(outer(p,a,"<"))}
power.M<-t(apply(p.M,2,pow,alpha))
power.Mstar<-t(apply(p.Mstar,2,pow,alpha))
dimnames(power.M)<-dimnames(power.Mstar)<-list(nam.param,nam.alpha)
power.M2p<-pow(p.M2p,alpha)
names(power.M2p)<-nam.alpha
mean.q.M.mc<-apply(q.M.mc,c(2,3),mean)
sd.q.M.mc<-apply(q.M.mc,c(2,3),sd)
mean.q.Mstar.mc<-apply(q.Mstar.mc,c(2,3),mean)
sd.q.Mstar.mc<-apply(q.Mstar.mc,c(2,3),sd)
mean.q.M2p.mc<-apply(q.M2p.mc,2,mean)
sd.q.M2p.mc<-apply(q.M2p.mc,2,sd)

OF<-mean(num.dead)/n
LF<-mean(num.dead.box)/n

q.M
q.Mstar
q.M2p
mean.q.M.mc
sd.q.M.mc
mean.q.Mstar.mc
sd.q.Mstar.mc
mean.q.M2p.mc
sd.q.M2p.mc
power.M
power.Mstar
power.M2p
OF
LF
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Appendix C: Numerical Optimization

library(survival)
mydata=read.csv("Jan16_R.csv",header=TRUE)
liver=mydata[c(7,8,10,12,13,14,25)]
dim(liver)
names(liver)
liver=liver[order(liver$surv5yr,-liver$censor5),]
liver=liver[rowSums(is.na(liver))==0,]
N=nrow(liver)
cen.t=liver$surv5yr
cen.ind=liver$censor5
dist=liver$Distance_from_home
hcv<-liver$hcv
hcc<-liver$hcc
cc0<-180
zz<-(dist>cc0)+0
mod<-coxph(Surv(cen.t,cen.ind)~zz+hcv+hcc)
summary(mod)
beta0<-mod$coef["zz"]
gamma0<-mod$coeff[c("hcv","hcc")]
tau0<-3.66
theta0<-0
# Specify initial values for parameters.
x0<-c(tau0,cc0,theta0,beta0,gamma0)
XX<-cbind(hcv,hcc)
DD<-cen.t[cen.ind==1]
nd<-length(DD)
d.ind<-(1:N)[cen.ind==1]
Dpos<-cbind(d.ind,1:nd)
RR<-outer(cen.t,DD,">=")+0
nx<-length(x0)
# f computes the log-likelihood for Extension #3.
f<-function(x) {
tau<-x[1]
cc<-x[2]
theta<-x[3]
beta<-x[4]
gamma<-x[5:nx]
AA<- as.vector(XX%*%gamma)+beta*(dist>cc)+theta*outer(dist>cc,DD>=tau)
sum(AA[Dpos]-log(colSums(RR*exp(AA))))
}
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###################################################################
parscale<-c(.5,20,.3,.3,.3,.3)
control<-list(fnscale=-1,parscale=parscale)
control.NM<-c(control,list(maxit=5000))
control.BFGS<-c(control,list(ndeps=c(.5,.5,rep(1e-03,4)),maxit=500))
control.SANN<-c(control,list(maxit=10000))
ans.NM<-optim(x0, f , method = "Nelder-Mead", control=control.NM)
ans.BFGS<-optim(x0, f , method = "BFGS" , control=control.BFGS)
ans.SANN<-optim(x0, f , method = "SANN" , control=control.SANN)
ans.NM
ans.BFGS
ans.SANN
# Different parameter estimates.
rbind(x0,ans.NM$par,ans.BFGS$par,ans.SANN$par)
# Improvements in log-likelihood relative to x0.
c(ans.NM$value,ans.BFGS$value,ans.SANN$value)-f(x0)
# Try random initial points.
rt<-range(DD)
nrep<-20
param.est<-array(NA,c(nrep,3,length(x0)))
for(i in 1:nrep){
xran<-c(runif(1,rt[1],rt[2]),runif(1,0,250),runif(4,-2,2))
param.est[i,1,]<-optim(xran, f , method = "Nelder-Mead",
control=control.NM)$par
param.est[i,2,]<-optim(xran, f , method = "BFGS",
control=control.BFGS)$par
param.est[i,3,]<-optim(xran, f , method = "SANN",
control=control.SANN)$par
}
# Improvements in log-likelihood relative to x0.
apply(param.est,c(1,2),f)-f(x0)
##############################################################
# My attempt Number 1 with different initial Values
gamma1=c(0.8,0.16)
x1=c(3,100,2,1,gamma1)
ans.NM.1<-optim(x1, f , method = "Nelder-Mead", control=control.NM)
ans.BFGS.1<-optim(x1, f , method = "BFGS" , control=control.BFGS)
ans.SANN.1<-optim(x1, f , method = "SANN" , control=control.SANN)
# Different parameter estimates.
cbind(x1,ans.NM.1$par,ans.BFGS.1$par,ans.SANN.1$par)
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# My attempt Number 2 with different Initial Values
x2=c(4,200,1,0,gamma1)
ans.NM.2<-optim(x2, f , method = "Nelder-Mead", control=control.NM)
ans.BFGS.2<-optim(x2, f , method = "BFGS" , control=control.BFGS)
ans.SANN.2<-optim(x2, f , method = "SANN" , control=control.SANN)
# Different parameter estimates.
cbind(x2,ans.NM.2$par,ans.BFGS.2$par,ans.SANN.2$par)
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